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Abstract
Uncoupling protein 2 (UCP2) is widely expressed in mammals but its true 
function has not been established. Present information suggests that like UCP1, UCP2 
functions as a proton leak and can uncouple productive mitochondrial respiration. This 
activity is reported to be functionally dependant on the presence o f ubiquinone. The 
expression o f UCP2 is reportedly increased during endotoxaemia, thus it may have a 
role in immune response.
This study examines the expression of UCP2 protein and its possible function 
during infection using endotoxamia in suckling rat pups as a model for neonatal sepsis.
The whole body response to endotoxaemia was investigated using indirect 
calorimetry. We report that endotoxamia induces hypometabolism and hypothermia in 
neonatal rats.
The expression pattern of UCP2 was investigated by developing a protocol for 
UCP2 western blotting and then using this to analyse appropriate mitochondrial 
samples from control and endotoxic suckling rats.
UCP2 expression was strongest in mitochondrial preparations from spleen and 
lung tissue. It was demonstrated that when compared to control samples, UCP2 
expression is increased and ubiquinone levels are decreased in mitochondrial 
preparations from lung tissues of endotoxic rat pups. The increase of UCP2 in 
endotoxic lung mitochondria could be the result o f macrophage infiltration and the 
decrease in ubiquinone may reflect recruitment of this compound to the plasma 
membrane. It is possible that the function o f uncoupling may be to protect sensitive 
tissues from damage by free radicals.
The role o f UCP2 induced uncoupling in macrophages was investigated by 
reactive oxygen species (ROS) assays. Using in vitro assays o f macrophage ROS
2
generation we demonstrate that known activators o f UCP2 such as TTNBP and 
ubiquinone enriched media can reduce the level of ROS
Our findings support other studies that suggest that UCP2 may be involved in 
protecting against the detrimental effects of ROS
3
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1. Introduction
1.1.1 Sepsis
Sepsis is part of the systemic inflammatory response to infection and can have 
broad ranging physiological manifestations in an affected organism1. Despite medical 
advances such as improvements in clinical practices and the introduction o f a broad 
range o f potent antibiotics, sepsis remains a major clinical problem with a high 
mortality rate . Investigations into the complex cellular and biochemical events that 
mediate sepsis are o f great importance and are particularly relevant to neonates, who 
with a reduced immune function are at particular risk when faced by sepsis .
Neonates that require surgery, parenteral nutrition, mechanical ventilation or 
those that are bom prematurely are at increased risk of sepsis. Systemic inflammatory 
response syndrome is a sepsis like state in the absence of a detectable infection. Animal 
models commonly generate a systemic inflammatory response using lipopolysaccharide 
(LPS). LPS is a product from the cell wall of bacteria that induces a systemic response 
with a well defined temporal cascade of various proflammatory cytokines4 (Figure 
1 . 1 .).
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Figure 1.1. Appearance of LPS and cytokines in plasma after LPS injection. Examples of typical 
temporal cascade of cytokines induced by LPS injection in an animal model of neonatal endotoxaemia 
TNFa -  Tumour Necrosis Factor alpha, IL-1 -  Interleukin 1, IL-6 -  Interleukin 6. Figure adapted from 
Anderson4
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During the early, acute phase of infection proflammatory cytokines such as 
tumour necrosis factor alpha (TNF-a) and interleukins IL-1, IL-6 and IL-8 prime 
neutrophils and macrophages for microbial killing5. Microbes can be destroyed by 
various cytokine induced mechanisms including an oxygen dependent mechanism that 
produces significant quantities of reactive oxygen species and free radicals that are 
highly toxic to pathogens. However, excessive free radical production can also damage 
host tissues.
In later stages of infection elements of the cytokine cascade become responsible 
for initiating a range of thermoregulatory responses. IL-1, TNF and IL-6 are all 
pyrogenic and cause an increase in body temperature by raising the set point of the 
hypothalamic thermoregulatory centre6. These cytokines induce the production of 
prostaglandins in the brain that activates neuronal pathways to increase heat production 
and decrease heat dissipation in the periphery6. However, rat models of endotoxaemia 
usually display an acute hypothermia that is generally followed by temperature
n
recovery . Compared to adults, neonates have greater difficulties in maintaining 
physiological body temperature and this hypothermia may increase the risks to 
neonates during infection. Thus, both hypo and hyper-thermia are amongst the clinical 
signs of sepsis in neonates1.
1.1.2. Mitochondria.
Mitochondria are the power houses that drive the majority o f ATP production.
As mitochondrial respiration is oxygen dependant, they are a major source of reactive
sf^cits 
oxygen sepsis.
The primary function o f mitochondria is to generate ATP via a process known 
as oxidative phosphorylation. Oxidative reactions that occur in the respiratory chain 
generate a proton gradient across the inner mitochondrial membrane and this gradient is 
used by ATP synthase to phosphorylate ADP to ATP8.
Mitochondria contain certain enzymes that pass on electrons or protons and can 
be sources o f ROS and in later stages o f sepsis can become a direct source of ROS
16
themselves5’9 . This can occur when the level of ROS overcomes the cellular protective 
scavenging systems and begin to have deleterious effects on mitochondrial oxidation.
1.1.3. Mitochondrial Proton Leak
Not all o f the energy from the electrochemical gradient is coupled to ATP 
synthesis. Some is used up by a proton leak, where protons pumped out of the matrix 
pass back into the mitochondria through pathways in the inner membrane, 
circumventing productive ATP synthesis. The proton flux across the inner 
mitochondrial membrane can be an important area of thermoregulatory control. It is 
now acknowledged that the inward flow of protons across the inner mitochondrial 
membrane via a route independent o f the FoFj ATP synthase is significant and that this 
proton leak could act to dissipate fuel-derived energy as h e a t10 (Figure. 1.2)
S u b stra te
R e s  jiratory ;hain
Figure 1.2. Diagram showing the transport of electron through the respiratory chain complexes (I- 
IV). The process is associated with pumping of protons from the mitochondrial matrix to the 
intermembrane space, creating an electrochemical gradient (ApH+) for ATP synthesis by ATP synthase 
(FoFd (1). Inward flow of protons independent of FoF] could be via an uncoupling Protein UCP (2) and 
may drive heat production. Additional routes of FoFj uncoupling could be by direct leakage of protons 
across the membrane (3), or coupled to ion transport (4)
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Studies in rats have shown that the proton leak may contribute up to 25% of the 
resting oxygen consumption and that the liver is responsible for approximately 20% of 
the overall standard basal metabolic rate. The liver may therefore be an important organ 
for thermogenesis.
Uncoupling may have roles in addition to a contribution to basal metabolic rate 
and adaptive thermogenesis. It is possible that mild uncoupling o f respiration could 
prevent the accumulation of mitochondrial generated oxygen radicals and also play a 
role in regulating ketogenesis, lipogenesis and amino acid synthesis by controlling the 
NAD+/NADH ratio"
The livers position between the portal and systemic circulation means that it is 
quickly exposed to substances translocated from the gut. Bacterial translocation across 
the gut can be an important source of bacterial entry, meaning that the liver can be one 
of the first organs exposed to the mediators of sepsis.
Impaired oxidative energy metabolism in hepatocytes has been reported in both
n.  1 '•y
adult and neonate models of endotoxaemia ’ . Due to little or no cytosolic disturbance 
being recorded, the metabolic disruption has been allied to an increased level of 
reactive oxygen species effecting mitochondria directly and inhibiting mitochondrial 
oxidation. Impaired mitochondrial metabolism has been linked to the decrease in core 
body temperature displayed by neonatal rat pups during endotoxaemia7. It is possible 
that this could be associated with the inhibition of the proton leak.
1.1.4. Uncoupling Protein 1
The first evidence that proton leaks across the inner membrane could be protein 
mediated was identified in 1978 and resulted from studies o f thermogenesis in Brown
i ^
Adipose Tissue (BAT) . This tissue is present in most mammals and produces heat in 
response to specific stimulys such as exposure to cold, birth and at the end of 
hibernation. It is well developed in large mammals around birth and present throughout 
the life span o f rodents. The topology o f its expression is specific so that once
18
activated, the heat it generates can be moved quickly through large vessels to the 
thorax, heart, brain and kidneys11.
BAT tissue is composed of brown adipocytes. These cells contain droplets o f 
triacylglyerols and have many specialised mitochondria with highly developed inner 
membranes. Measurements of oxygen consumption of isolated brown adipocytes 
confirmed that they had a marked oxidative capacity11.
Studies have shown that the main areas of control for BAT activity are the 
thermoregulatory centres of the hypothalamus14. It was discovered that in response to 
certain stimuli these centres triggered sympathic nerves that increased oxygen 
consumption and heat production in BAT, by releasing norepinephrine to the surface o f 
the brown adipocytes. Since norepinephrine activates lipolysis, it was proposed that this 
heat production was related to the increased oxidation o f fatty acids.
Observations that the respiration of mitochondria isolated from BAT was 
loosely coupled to ADP phosphorylation and that uncoupling was activated by fatty 
acids and inhibited by purine nucleotides indicated that a controllable uncoupler existed 
in the inner mitochondria membrane15. Photo-affinity labeling experiments identified a 
32 kDa protein as the binding site for these purine nucleotides and led to this protein 
being presented as the putative uncoupling protein, UCP . Sequencing and cloning 
experiments that reproduced this protein’s proton translocating ability in liposomes16 
gave rise to general acceptance that this protein was responsible for regulated 
uncoupling of BAT mitochondria. However, final proof that UCP was in fact the 
molecular key to adaptive thermogenesis did not come until 1997 when null mutant 
mice were shown to be unable to maintain their body temperature in a cold 
environment17. The BAT uncoupling protein was known simply as UCP until studies 
indicated the presence of other UCPs (see section 1.1.5), when it was renamed UCP1.
UCP1 causes heat production in BAT by acting as a proton leak. It has been 
demonstrated that norepinephrine induced lipolysis and the increase in the
1 Rconcentration of free fatty acids activates UCP1 . Once activated UCP1 allows protons 
and anions to move across the inner mitochondrial membrane, dissipating the 
electrochemical gradient. This decreases the membrane potential and increases the
19
respiratory rate19. This pathway is not coupled to any energy consuming process and 
bypasses proton transport by the ATPase and thus ADP phosphorylation. Under these 
conditions the most o f the energy from oxidation is released as heat (Figure 1.3). 
Adrenergic stimulation has also been found to boost UCP1 gene transcription.
Figure 1.3. Accepted pathway for the stimulation of UCP1 activity by norepinephrine (NE). NE
binds to receptors on the surface of brown adipocytes that increase cAMP levels, stimulating lipolysis 
and the generation of FA that stimulate UCP1 mediated uncoupling and consequent heat production.
The activity of UCP1 has been shown to be inhibited by nucleotides and
90activated by non-esterified fatty acids .
Uncoupling by UCP1 is a relevant thermogenic mechanism involved in body 
temperature regulation in small mammals and rodents. However, the limited expression 
of BAT in adult humans and other large mammals mean that other mechanisms must be 
responsible for controlling whole body thermogenesis and energy expenditure.
20
1.1.5. Other Uncoupling Proteins
As the proton leaks exist in tissues other than BAT it could be regulated so 
rather than a constant leak o f protons, they could provide a viable, physiological role. 
This hypothesis led researchers to screen a skeletal muscle library for similar proteins 
using UCP1 cDNA as a low stringency probe. These experiments concluded in 1997
71with the cloning o f a second uncoupling protein (UCP2) . which shares a 59% amino
9 1acid sequence homology with UCP1 . Further cloning experiments led to the 
discovery o f other UCP1 homologues such as UCP322, UCP423 and brain mitochondrial 
carrier protein I (BMCP-1)24. For the purpose of this study discussion will be focused 
on UCP2.
Structural modelling studies have indicated that UCP2 conforms to the same
• 9 Striplicate structure that is typical of all inner membrane mitochondrial carriers . Each 
of it’s three domains has been shown to contain the mitochondrial energy transfer site 
and it has been predicted that each of these contain two transmembraneous helices, 
linked by a matrical loop between the N- and C- terminus, with cytosolic orientation. A
9 f \similar model is proposed for UCP1 . Members of the mitochondrial carrier family, 
which include the UCPs, have been shown to have two transport modes: a substrate- 
specific carrier activity and a less specific channel activity. Evidence suggests that that 
this character is reflected by UCP1 and 2 by the structural organisation of the two 
transmembraneous helices that are proposed to form a channel and a gating domain. 
Studies with UCP1 have suggested that matrix loops that link the transmembrane 
helices may contribute to the formation of a gating domain that could be a focus for
27controlling the transport activity of this protein .
In situ hybridisation has been used to describe UCP2 expression. UCP2mRNA
has been found in heart and muscle tissues, in white adipose tissue, the brain, stomach,
small intestine, gut, liver, kidney, pancreas and throughout the immune system, in all
21organs containing macrophages and lymphocytes .
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1.1.6. Uncoupling Function of UCP2
The sequence and structural homology between UCP1 and 2 have led to the 
suggestion that like UCP1, UCP2 uncouples productive respiration. The ubiquitous 
nature o f UCP2 expression led to hypotheses linking this proteins function with whole 
body temperature regulation and weight regulation. However, the similarities between 
UCP1 and 2 are not sufficient to determine whether their uncoupling pathways are the 
same in terms of molecular and regulatory mechanisms, let alone what the 
physiological function of UCP2 might be. Interestingly, the amino acid sequence of 
UCP2 lacks two histidine residues that have been argued to be essential for proton 
transport in UCP1 . Despite the significant homology with UCP1 it is possible that 
UCP2 does not have an uncoupling function.
Most investigations into the uncoupling function o f both UCP1 and 2 have been 
based on the use o f heterologous expression systems. Several groups have used 
Saccharomyces cerevisiae for UCP activity analysis21,29. Expression of UCP1 and 
UCP2 in this have model appeared to confirm their uncoupling function. However, 
unlike UCP1, UCP2 uncoupling in isolated mitochondria from Sacaharomyces 
cerevisiae did not demonstrate a dependence on fatty acids or inhibition by purine
O A
nucleotides . This result has been taken to mean that uncoupling in UCP2 is different 
to UCP1. The reduction in mitochondrial membrane potential and increase state 4 
respiratory rates that have been reported with UCP2 expression in yeasts21 indicate that
90uncoupling is occuring . However, it is possible this uncoupling is not intrinsic to 
activity of UCP2, but occurs as a result of impaired mitochondrial integrity due to over 
expression of UCP2 in the membrane.
Some studies have reported that UCP2 expression in yeast reduces fully
1 1
uncoupled respiration rates in isolated mitochondria ’ . This can affect the estimated 
value of respiratory control that is calculated as the ratio o f the fully uncoupled rate to 
state 4 respiration. There is no reason why uncoupling resulting from UCP2 expression 
should affect fully uncoupled respiration rates and in these cases decreased respiratory 
control should not be seen as confirmation of uncoupling activity. A decrease in 
respiratory control may well indicate a dysfunction o f the respiratory chain rather than 
confirm uncoupling by UCP2 expression.
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Another criticism of the experiments with transfected yeast models has been 
that none have measured the expression levels o f the UCP homologues and that in 
some cases the presence and function of the protein have been inferred by the 
uncoupling phenotype. It is possible that uncoupling may be the result o f a general 
disruption o f mitochondrial physiology rather than the activity o f a specific protein. 
Recent experiments on UCP1 expression in yeast demonstrated that low level 
mitochondrial expression of this protein led to GDP sensitive uncoupling. However, at 
higher levels o f expression uncoupling became GDP insensitive, suggesting that
32uncoupling could be an artefact in yeast mitochondria .
The third argument against the validity o f the use o f yeast expression systems to 
report uncoupling by UCP is that amount o f protein expressed in these systems do not 
reflect the native level of UCP in mammalian mitochondria. Proteins are generally far 
over expressed in transfected models and it is possible that this renders observation of
IT
uncoupling activity, physiologically irrelevant . The level o f UCP2 and UCP3 protein 
expression in mammalian mitochondria is extremely low.
These arguments could be levied at the some of the conclusions drawn from 
similar transfection studies of uncoupling with UCP1. However, uncoupling in yeast 
cells transfected with UCP1 has been reported as GDP sensitive at physiologically 
relevant levels and UCP1 uncoupling has already been well characterised when isolated 
from its native tissue34'36. It has not been possible to isolate UCP2 due to its low tissue 
content. Therefore studies have relied on transfection systems such as Saccharomyces 
cerevisiae or Escherichia coli. Recent experiments have suggested that UCP2 
expression in yeast differs from UCP1. It has been reported that it is expressed in a 
deranged form in Saccharomyces cerevisiae and it is possible that it is an unsuitable 
host for UCP2 expression37.
1.1.7. Ubiquinone and UCP function.
Initial experiments with Escherichia coli were unable to demonstrate proton
TO
transport activity from any UCP expressed E.coli inclusion bodies . Rather than
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disregard the uncoupling hypothesis, Echtay et a\ continued their enquiries into why 
expression in inclusion bodies failed to support UCP uncoupling . Experiments began 
with UCP1 because a greater body o f evidence for uncoupling existed for this member 
of the uncoupling family13,17. By screening lypophilized mitochondria extracts for their 
ability to activate proton transport in liposomes including UCP1 and submitting active 
fractions to silica gel column chromatography, a lipid soluble co-factor was discovered
■y o
that was essential to uncoupling activity . Analysis of its absorption spectra identified 
this compound as ubiquinone^ (UQio), (commonly known as coenzyme Q). Addition 
of pure UQio to the inclusion bodies was shown to cause a stimulation o f proton 
transport that could be inhibited by purine nucleotides. Ubiquinone has also been 
reconstituted from native UCP1 and a structural requirement has been reported with 
respect to the length o f its hydrophobic side chain; activation of proton transport 
decreased with a shorter isoprenoid chain. It has been shown, by using ubiquinone in 
conjunction with fatty acids, that nucleotide sensitive proton transport rates can be 
matched to those found in native UCP1. This confirms that UCP1 uncoupling can be 
reproduced in E.coli inclusion vesicles and that ubiquinone is an obligatory co factor
TO
for this function .
Later experiments confirmed that both UCP 2 and 3, when reconstituted under 
the same conditions for UCP1 activation, could exhibit nucleotide sensitive proton
T 7transport activity and were functionally dependent on ubiquionone . Like UCP1, 
Uncoupling with UCP2 and 3 has a functional requirement for the hydrophobic side 
chain. Optimal proton transport rates have been achieved with isoprenoid lengths of
T7between 10 and 13 units . It is possible that this indicates that ubiquinone has to be 
embedded deeply in the membrane in order to interact with UCP. UCP3 has been 
demonstrated to accept shorter chain lengths for activation which may suggest that the 
quinone docking site is less deeply embedded37.
The requirement for fatty acids (FA) that accompanies the cofactor role o f 
ubiquinone for uncoupling suggests that they may associate directly for this function. 
Both compounds are bound to the phospholipids o f the inner mitochondrial membrane, 
whereas the hydrophilic carboxyl group of FA would bind to the phospholipid head 
groups of the membrane, the quinone group of ubiquinone would easily penetrate into 
the hydrophobic layer. It is possible that by forming a hydrogen bond between the
24
quinone oxo group and the FA carboxyl group, ubiquinone may allow the entry of 
undissociated FA (FAH) into the hydrophilic membrane and through the proton 
transport route o f its associated UCP. It is possible that ubiquinone has a catalytic role 
and takes the proton from FAH and passes it into a proton acceptor group of UCP37 
(Figure 1.4.).
Figure 1.4. Possible mechanism for role of Ubiquinone as an essential co-factor for UCP 
uncoupling. Undisassociated Fatty Acid (FAH) forms a hydrogen bond with the quinone oxo group 
bound to UCP. This complex eases the delivery of FA carboxyl to UCP, where it donates H+ to an 
acceptor group. The FA' diffuses back to the surface where it obtains another H+ 38
1.1.8. Physiological nature of Uncoupling proteins.
The structural similarities reported for the UCP proteins that included the 
conservation o f domains for binding nucleotides and for proton transport led to the 
suggestion that these proteins shared a common function39. The finding that liposomes 
expressing UCP2 and-3 can demonstrate regulated proton transport supports this initial
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hypothesis and would seem to justify the extension of the term uncoupling from UCP1, 
to UCP2 and 3.
Several physiological roles for UCP2 and 3 have been proposed based on their 
supposed uncoupling function and expression pattern. Genetic studies have suggested 
they might be linked to hyperinsulinism or to resting metabolic rate and hence the
9 1control o f body weight and the wide spread expression o f UCP2 have led to 
suggestions of a role for UCP2 in diet induced thermogenesis, fever and possibly in the 
regulation o f reactive oxygen species production40.
Most o f these studies into the physiological role o f UCP2 and 3 have been 
based on the variations of mRNA levels for these proteins41. Although this is a valid 
procedure for recognising the factors that affect UCPs at the transcription level, it is not 
a precise indication o f UCP activity or function. The level o f UCP2 mRNA expression 
in the liver and reports that LPS and TNFa induce UCP2 expression in hepatocytes led 
to the suggestion that UCP2 may have a role in fever response and thermogenesis42’43. 
However, investigations into the level of UCP2 protein expression have thrown doubt 
on this hypothesis. Using a highly sensitive polyclonal antibody for UCP2, a large 
disparity has been demonstrated between UCP2 mRNA and UCP2 protein expression. 
UCP2 mRNA has been found in many organs in which it is expressed at different 
levels. However, the protein has only been detected in a limited number of organs. 
UCP2 protein has been detected in spleen, lung (stomach and white adipose tissue, yet 
none has been detected in the heart, skeletal muscle or importantly the liver. Even in 
the organs where UCP2 expression is at its highest, the lung and spleen, the amount of 
UCP2 protein is 2 orders o f magnitude lower than that o f UCP 1 in BAT mitochondria. 
Reports indicate that the level o f native protein expression is too low to suggest that 
UCP2 can trigger thermogenesis by strong mitochondrial uncoupling33. An analysis of 
UCP2 protein expression in several organs after LPS exposure has reported an increase 
in expression in both lung and stomach tissues41. The kinetics o f the induction of UCP2 
protein after LPS injection were shown to be consistent with a primary immune 
response leading to oxidative burst in the lung41. It is possible that UCP2 does not have 
a function under basal conditions, but is activated when the level of intracellular ROS is 
too high. In this way its function could be to protect certain tissues from oxidative 
stress that could be provoked by infection, pollution or allergy.
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1.1.9. Studies in UCP2 Knock-out mice ( / ).
One way to determine a proteins’ function within an organism is to remove it 
and then study the effects on the organism’s physiology. Late in 2000, Arsenijevic et al
s '
generated UCP2 deficient mice by homologous recombination in stem cells44. These 
mice developed normally, but had no UCP2 expression, confirmed by western blot 
analysis o f mitochondria and northern blot analysis o f tissue mRNA. It was found that 
UCP2 ablation had no effect on cold induced thermogenesis or on body weight 
regulation.
The responses of UCP2 mice to cold exposure and a high fat diet did not 
differ from that of wild type mice, suggesting that UCP2 does not play a major role in 
energy balance. The extensive distribution of UCP2 mRNA within tissues of the 
immune system in wild type mice led investigators to explore the immunological 
phenotype of this knock out model. UCP2 mice were infected with Toxoplasma 
gondii, an intracellular parasite that infects the brains of normal mice causing death.
All wild type mice in this experiment died between 28-50 days after infection 
with Toxoplasma gondii, yet the UCP2 ^  mice were completely resistant even 80 days 
after infection. In vitro studies on their isolated macrophages demonstrated that the 
pathogen was eliminated more efficiently in the absence o f UCP2 as compared to 
isolates from wildtype mice44. Somehow the macrophages o f the mutant mice had 
increased toxoplasmacidal and bactericidal activity, a very surprising finding. It is well 
known that stimulated macrophages produce ROS that have powerful toxoplasmic^dal 
effects and that mitochondria are the main source o f these ROS45. Further studies 
demonstrated a higher rate of ROS production in UCP2('/') macrophages compared to 
control macrophages44. It seems that disruption o f UCP2 alters macrophage activity in 
the presence o f a pathogen by affecting their level of ROS.
It is therefore possible that UCP2 might be o f importance to mitochondrial ROS 
production and that an alteration in mitochondrial membrane potential could be 
reflected in mitochondrial superoxide generation. An increase in mitochondrial 
membrane potential would slow the transport o f electrons through the respiratory chain, 
increasing the amount o f time for interaction between electrons and molecular oxygen
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facilitating ROS formation. As a respiratory uncoupler, UCP2 may act to vent the 
membrane potential thus decreasing ROS generation. It has been proposed that mild 
uncoupling o f respiration by UCP2 regulates ROS by modulating protein leakage 
through the inner mitochondrial membrane44. However, it is also possible that in the 
absence o f UCP2, there is an increase in NADPH concentration, the substrate for 
NADPH oxidase to generate superoxide.
1.1.10. UCP2 uncoupling in macrophages
Isolated macrophages challenged with endotoxin demonstrated a decrease in 
UCP2 mRNA that was associated with an increase in ROS44. Thus, it seemed that 
increases inUCP2 could be active in the limitation o f ROS and an act as antitoxidant 
defence. Decreases in UCP2 expression could be used as a mechanism whereby 
macrophages could increase their bactericidal power by increases in ROS production. 
Increases in UCP2 may be a tissue specific response to prevent excessive oxidative 
stress in response to infection, food restriction or even exercise. In addition, previous 
studies that indicated increases in UCP2 mRNA expression in different tissues could 
reflect macrophage infiltration in that tissues rather than UCP2 expression in the native 
cells of that tissue.
1.1.11. Activation of UCP induced uncoupling
If uncoupling proteins are involved in regulating the level o f ROS, the next 
question is how this response is initiated. Retinoic acid has been shown to strongly 
increase proton transport by UCP1 in brown adipose tissue mitochondria and in yeast 
mitochondria expressing UCP l 46. Given the similarities between UCP1 and 2 it is 
possible that UCP2 may also be sensitive to retinoic acid. Experiments using the yeast 
expression system for UCP2 suggest that UCP2 uncoupling activity can be influenced
T A
by retinoic acid, but only across a certain pH range . It has been argued that yeasts are 
not a suitable expression system for studying UCP233. Strong evidence for retinoid 
activation o f UCP2 has been provided by a study of the respiratory rates o f thymocytes 
from wildtype and UCP2('/‘) mice. Retinoids have been shown to increase the
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respiratory rate in thymocytes o f normal mice but not in those isolated from UCP2'7' 
animals47.
Ubiquinone has been identified as a regulatory cofactor for uncoupling in 
UCP1, UCP2 and UCP3 in liposomes37,38 (See section 1.2.5.). In the search for an in 
vivo regulator further studies have examined the effect o f ubiquinone in isolated 
mitochondria. Ubiquione has been found to increase proton transport in mitochondria 
isolated from rat kidney but not liver. This increase was dependent on the presence of 
fatty acids and inhibited by purine nucleotides. The addition of superoxide dismutase 
completely abolished the activation of proton transport thus it was proposed that 
ubiquinone might be mediating uncoupling through the production of superoxide48. To 
test this hypothesis xanthine plus xanthine oxidase, an exogenous system that generates 
superoxide, was added to isolated mitochondria. Proton conductance increased in 
mitochondria expressing UCPs suggesting the ubiquinone did indeed act in these 
mitochondria through the production of superoxide. Once again this increase was fully 
inhibited by superoxide dismutase and by purine nucleotides48. The effect o f 
superoxide has also been reported to require fatty acids. It has been demonstrated that 
the addition o f bovine serum albumin (BSA), an agent that binds fatty acids, abolishes 
the increase in proton conductance and that reactivation only occurs when the effects of 
BSA are countered by Palmitic acid. Superoxide induced, nucleotide sensitive and 
fatty acid / dependent proton conductance has only been reported in isolated 
mitochondria that express UCPs. Given this and that the conditions for stimulated 
uncoupling by superoxide mimic those for required for uncoupling in UCP expressing 
liposomes, superoxide seems a likely candidate for an activator o f UCP activity.
Two models have been proposed for the mechanism by which superoxide may 
activate proton transport. The first suggests that superoxide directly activates UCPs by 
an allosteric interaction that induces proton transport by the mechanisms previously 
proposed for UCP l 49. The second suggests that superoxide anions in the matrix are 
exported to the intermembrane space by the UCPs and once here they undergo rapid 
dismutation due to the more acidic pH or by antioxidant defences. It has been proposed 
that the resulting hydroperoxyl radical would diffuse back into the matrix and the 
superoxide anions would then be exported by UCP10. If this model were correct then
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uncoupling would only become evident when the matrix was flooded with exogenous 
superoxide.
Both models indicate that UCPs could decrease ROS production by mild 
uncoupling and that this could be a feedback response to the overproduction of ROS by 
the electron transport chain. A recent study has provided evidence to support the first 
model and has suggested that UCP2 is activated by superoxide from the matrix side of 
the mitochondrial inner membrane. Following the same methodology o f previous 
experiments48, studies with isolated mitochondria were performed in the presence o f 
high concentrations o f superoxide that was generated using xanthine plus xanthine 
oxide50. This group first established that exogenous superoxide anions could actually 
reach the mitochondrial matrix by measuring the activity o f aconitase, a matrix enzyme 
which is highly sensitive to superoxide. Compared to controls, aconitase actively was 
significantly reduced in isolated mitochondria with xanthine plus xanthine oxide. This 
clearly demonstrated that exogenous superoxide anions could reach the mitochondrial 
matrix. This matrix exogenous superoxide was then targeted by covalently linking the 
antioxidants ubiquinone and tocophenol to a lipophilic cation that could penetrate the 
lipid bilayers and thus accumulate in the mitochondria when a membrane potential was 
present50. The superoxide induced uncoupling demonstrated in the presence of xanthine 
plus xanthine oxide was shown to be completely inhibited by these targeted 
antioxidants. Non targeted antioxidants had no effect suggesting that uncoupling could 
only be prevented by destroying the matrix superoxide.
The role of matrix superoxide as an activator of uncoupling by UCP2 has been 
investigated by increasing the level o f superoxide specifically within the mitochondrial 
matrix. The moiety of ubiquinone cycles between oxidised and reduced form by
* 51 * 52exchanging electrons with the respiratory chain ’ . Under reducing conditions the 
ubiquinone can accept electrons from the respiratory chain and can itself become a 
source o f superoxide. By titrating isolated mitochondria containing matrix targeted 
ubiquinone with cyanide (an inhibitor of complex IV), it was possible to produce a 
gradual increase in superoxide as it was generated by the progressively reduced matrix 
ubiquinone. This was shown to induce GDP sensitive uncoupling. It has been proposed 
that this increase in uncoupling occurred through the interaction between matrix
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superoxide and UCP2 and not by futile cycling of superoxide through the extra 
mitochondrial space.
It is not possible to extend these finding to whole cells or organisms, because 
the studies were performed in isolated mitochondria in the presence of high 
concentrations of superoxide. However, these studies results could explain the 
increased production of matrix ROS reported in mitochondria o f UCP2 knockout mice 
and add to the increasing body of evidence that UCP2 is not involved in thermogenesis^ 
but that it functions as a regulator of ROS.
1.2. Discussion
Despite extensive research, the true function of UCP2 remains elusive. It was 
initially suggested that UCP2 catalyzed mitochondrial proton conductance20. 
Investigations into the function of UCP2 in isolated mitochondria have proved difficult 
due to the low level of native UCP2 protein expression.
Abundant expression of UCP2 protein has been achieved in E.coli inclusion 
bodies and,^when reconstituted in phopholipid vesicles, demonstrated to have proton 
transport activity. These studies have identified ubiquinone as an essential cofactor of 
in vitro uncoupling by UCP1, 2 and 3 and shown that these proteins do share the
T7essentially the same functional characteristics . Although recombinant expression and 
reconstitution experiments allow the potential biochemical activities of these proteins 
to be described they can not suggest which are physiologically relevant.
Evidence from UCP2 knockout studies have indicated that its uncoupling 
activity does not contribute to the basal proton conductance of mitochondria, but that 
its function is to regulate the level of ROS in certain cells, such as macrophages44.
Different claims have been made for the regulation of UCP2 by ubiquinone, fatty acids, 
nucleotides18 and lately, by retinoids30 and superoxide48. The reported direct effect o f 
superoxides on UCP2 activation fits well with the observation that UCP2 expression 
occurs under conditions o f oxidative stress. UCP2 activity is influenced by retinoids
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only within thymocytes47 and the effect of UCP2 gene knock out is only evident in 
certain cells44. This evidence suggests that UCP2 functionality may be limited to 
specific cell types, in particular macrophages, thymocytes and B-cells.
Evidence to date indicates that although UCP2 has similar bioenergetic 
characteristics to UCP1 its physiological function is not thermogenesis, but regulation 
of ROS. UCP1 was the first uncoupling protein to be discovered, however in terms of 
evolution is younger than UCP2. It has been speculated that UCP Is ’ thermogenic role 
in mammals evolved from a more general function of protection against cold induced 
ROS production. This function for UCP2 can explain the association of this protein 
with cells o f the immune system, the observation of nucleotide sensitive ROS 
production in cells expressing UCP2 and could be the reason that UCP2'7' mice are 
resistant to endoparasite infection.
1.3. Aims
The aim of this study was to examine the expression of UCP2 protein and its 
possible function during infection, using endotoxaemic suckling rat pups as a model for 
neonatal sepsis. The whole body response to endotoxaemia was examined by indirect 
calorimetry and the effects of endotoxaemia on UCP2 protein expression were assessed 
by western blotting. The role of UCP2 tnediated uncoupling in specific cells was then 
investigated using an in vitro assay of macrophage induced ROS production. Our 
findings support the hypothesis that UCP2 has a role protecting specific cells against 
ROS.
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2. Whole body energy metabolism of endotoxic suckling rat
pups.
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2. Whole body energy metabolism of endotoxic suckling rat pups.
2.1 Introduction.
Sepsis is a major cause of morbidity and mortality in neonates. Its physiological 
manifestations are diverse and mediated by complex cellular and biochemical events. 
Sepsis has an impact on the metabolic control o f mammals and can elicit a range of 
thermoregulatory responses53. Clinical signs of neonatal sepsis include hypo- or 
hyperthermia1.
A locus for the metabolic responses driven by sepsis could be proton flux across 
the inner mitochondrial membrane. It is known that futile cycling o f protons though the 
proton pumps that drive ATP consumption can modify metabolic efficiency and in 
some cases have been proved to drive heat production15. UCP1 has been identified as 
the molecular key for this process in brown adipose tissue (See Chapter 1). The high 
level of mRNA expression reported in various tissues for UCP2 has lead to the 
suggestion that this protein may be involved in whole body thermoregulation. As 
lipopolysaccharide injection increases UCP2 mRNA expression in liver and in other 
tissues, an effect on whole body energy metabolism could be mediated via UCP2.
Studies suggest that in adults the metabolic response to sepsis consists of a 
short, initial, hypometabolic phase that is followed by a more prolonged 
hypermetabolic response54. Neonates have a reduced immune function and their 
metabolic response to sepsis has not been clearly defined. Infants with sepsis frequently 
present with hypothermia1,55, but it is not known whether transient hypometabolism 
occurs that may contribute to the observed condition. Studies with children have 
reported that their hypermetabolic response to sepsis may be short lived or non­
existent1,56.
The aim of the study was to investigate respiratory gas exchange and body 
temperature in suckling endotoxaemic rats to determine the effects of endotoxaemia in 
this model. Any changes in whole body energy metabolism can then be related to 
changes in UCP2 expression (see chapter 4).
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2.2. Methods
Animals
Single litters of 11-13 day old Wistar rat pups were split into two groups of five 
and allowed to suckle freely with the mother until the start o f the experiment. The 
experiment commenced with each rat pup being given a single intraperitoneal injection 
of either 0.9% saline (control group C) or saline plus 300 pg/kg lipopolysaccharide 
(LPS, E.coli 0.55:B5, Sigma, Poole, Dorset, U.K) (endotoxic group E) at 0.024ml/g 
body weight. Weight and rectal temperatures were measured hourly throughout the 
time course o f the experiment. Rectal temperature was measured with a digital probe 
and hypothermia was defined as rectal temperature less that 32°C.
Endotoxaemia score
A scoring system was adapted from a system created for adult rats was used to
n
assess the degree of sepsis in each rat pup
M obility
0 The rat pups will not allow them selves to be supine
2 The rat pups can be turned supine for a few seconds
4 The rat pups can be turned supine for more than 5 seconds
6 The rat pups will not turn back over when turned supine
P ow er
0 The rat pups can dangle from a finger for more than 5 seconds
1 The rat pups can dangle from a finger for less than 5 seconds
2 The rat pups cannot dangle from a finger
Shivering
0 N o shivering
1 Shivering
Figure 2.1. Sepsis scoring table. The score of shivering is additional. If the total score is 8 for mobility 
and power then shivering is not counted, i.e. maximum score of 8 (Very ill); minimum score of 0 (no 
signs of illness).
35
Indirect Calorimetry
Measurement of respiratory gas exchange was performed using an indirect 
calorimeter (Oxymax, Columbus Instruments, Columbus, Ohio). The set up consisted 
of a sealed perspex chamber in which the flow rate could be adjusted; this was 
connected to an infra-red CO2 analyser and an electrochemical O2 sensor. The rate of 
airflow through the chamber was between 0.3-0.5 litres per minute, and this gave a 
difference in O2 between the inflow and outflow from the chamber o f approximately -  
0.3%. The O2 and CO2 sensors were set to zero using oxygen free N 2 and then 
calibrated using a mixture of 20.5% O2 , 0.5% CO2 and 79.0% N 2 (BOC, Special Gases, 
Guildford, Surrey).
The rat pups were placed in the calorimeter chamber in groups of five and 
assessed for a period of 30 minutes at a time. The temperature o f the chamber was 
monitored throughout indirect calorimetry assessment. After this period, the rats were 
returned to their mother and allowed to suckle freely for a minimum of 30 minutes, 
before the next round of assessment. Data were collected every minute and averaged 
over each 30 minute period; O2 consumed (V 0 2) and CO2 produced (VCO2) were 
expressed in ml/kg/min. Respiratory quotient was calculated as VCO2/VO2
Statistical evaluation
Results were normally distributed and are expressed as mean ± SEM. VO2 and 
endotoxaemia score were compared by ANOVA with Tukey’s Multiple Comparison 
post-hoc test, or by paired t-tests where animals from the same litter were compared. 
Incidence of hypothermia was compared between groups by Fisher’s exact test. Prism
3.02 and Instat 3.05 (Graphpad software, San Diego, California, USA) were used for 
statistical comparisons.
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2.3. Results
2.3.1. Temperature and endotoxaemia
Cage temperature remained at 23.9+0.1 °C throughout the study. The rectal 
temperature of LPS injected groups dropped at 90 minutes post injection and remained 
lower than the control group throughout the experiment (Figure 2.2.).
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Figure 2.2. Effect of Endotoxeamia on rectal tem perature: Rectal temperatures were measured hourly 
with a digital probe. Hypothermia was defined as temperature below 32°C. Empty circles = 
measurements from control rat pups (Mean±SEM, n=45) Filled circles = measurements from endotoxic 
rat pups (Mean±SEM, n=49). Data that is significantly different from control is marked with an asterisk 
p<0.005. Ambient cage temperature remained at 24°C±0.12 (Mean±SEM)
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2.3.2. Oxygen Consumption.
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Figure 2.3. Oxygen Consumption. Values for oxygen consumption are given as mean±SEM. Empty 
circles = measurements from control rat pup. Filled circles = measurements from endotoxic rat pups. 
p<0.005 n=8 paired t-test There was a significant difference between control and septic groups as marked 
by asterisks.
Oxygen consumption was at 1062±43 ml/kg/min for all rats before injection. 
This dropped slowly during the course o f the experiment with the control group 
reaching 725± 110 ml/kg/min at 210 minutes. Oxygen consumption dropped even 
lower in endotoxic rats, resulting in a large significant difference in VO2 between 
control and endotoxic groups (Figure 2.3).
38
2.3.3. Correlation between V02 and body temperature
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Figure 2.4. Tem perature and oxygen consumption. Values for temperature are given as an average for 
each group of rats analysed at a specific time point. Values for oxygen consumption represent that of the 
whole group. (A) displays the results from endotoxic rat pups, (B) displays that from controls.
There was a strong positive correlation between V 02  and rectal temperature in 
the endotoxic animals (fig.2.3) (p< 0.001, R =0.43). The range of rectal temperatures 
measured in the control groups was insufficient to evaluate whether there was a 
relationship between temperature and VO2
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2.3.4. Endotoxaemia and respiratory quotient.
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Figure 2.5. Respiratory Quotient. Each value for respiratory quotients represents an average for the 
five rats in the chamber at each time. Empty circles = measurements from control rat pups. Filled circles 
= measurements from endotoxic rat pups. A significant difference in values between control and 
endotoxic groups did not occur until after 150 minutes (p=0.05 at this time point). Values expressed as 
Mean±SEM.
The respiratory quotient (RQ) reflects the balance of its substrate oxidation. For 
net fat oxidation this is expected to be 0.71 and is set at 1.00 for net carbohydrate 
oxidation, lipogenesis can result in RQs of greater than 1. Respiratory quotients for 
both control and endotoxic groups remained between 0.71 and 0.78 suggesting a 
predominance of fat oxidation throughout the duration o f the experiment, that is 
expected for rats o f the age (Figure 2.5). Endotoxic rats did show a slight increase in 
RQ when compared to controls at 150 and 210 minutes. This could reflect a minor 
inhibition of fat oxidation and/or a shift to carbohydrate oxidation.
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2.3.5. Endotoxamia Score
Only data from rat pups that demonstrated a physiological response to the LPS 
injection were used in the final analysis and these rats showed an increase in 
endotoxaemia score over time. Most rats had a response to LPS, a lack of response was 
most probably due to miss-injection of the endotoxin
2.3.6. Carbon dioxide production and energy expenditure
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Figure 2.6. Carbon dioxide production. Values for carbon dioxide production are given as
-5
mean±SEM. Empty circles = measurements from control rat pup. Filled circles = measurements from 
endotoxic rat pups. p<0.05 n^S paired t-test There was a significant difference between control and 
septic groups as marked by asterisks.
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Figure 2.7. Heat production. Values for heat production are given as mean±SEM. Empty circles = 
measurements from control rat pup. Filled circles = measurements from endotoxic rat pups. n=8. Heat = 
calorific value x V 0 2. Calorific value =3.815 + 1.232 x RQ (Manufacturers recommendations).
As the RQ remained relatively unchanged throughout the course of the 
experiment the fact that the changes in both VCO2 and heat production mirrored by 
those in VO2 was to be expected. As VO2 is the major contributor to energy 
expenditure, the graph of energy expenditure over time is similar to that of VO2 .
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2.4. Discussion
Cardiac mitochondrial function and hepatocyte oxidative metabolism has been 
shown to be inhibited in ex vivo studies on tissues isolated from this suckling rat model 
of peritoneal sepsis7. Here we have shown that this is accompanied by 
hypometabolism, which may contribute to the hypothermia observed in these rats.
The oxygen consumption of saline injected animals also dropped during the 
course of the experiment. It is probable that this is due to the repeated handling and 
measurement o f rectal temperatures o f the control animals. VO2 and temperature were 
both significantly lower in endotoxic rats as compared to control group.
The low rectal temperature (~ 34°C) of the suckling rats is in keeping with the
c n
findings of other studies of rats at this age . The observed effects of endotoxin on VO2
c o
and temperature are in agreement with those of DeRijk et al in adult rats. Although 
other authors have shown increases in both VO2 and body temperature in adult rat 
endotoxaemia, these responses vary with both dose and serotype of endotoxin59. 
Studies in infants and children have not demonstrated a hypometabolic phase of sepsis1. 
It is possible that this occurs early in sepsis and consequently has not been observed in 
clinical studies
The respiratory quotient of these rats was low at around 0.75. Similar RQs have 
been found by many authors and reflects the reliance of suckling rats on fatty acids as 
an oxidative fuel. Respiratory quotients have not been corrected for urinary nitrogen 
output so this figure does include a component of protein oxidation. As mixed protein 
oxidation has a RQ of 0.835, protein oxidation does not seem to be high in either 
groups.
Rats at this age feed almost continually. In order to avoid starvation the rat pups 
were put back with their dams for 30 minutes every hour throughout the experiment. 
All rat pup stomachs were found to be distended with milk at sacrifice and laparotomy 
supporting lack of starvation of both the control and endotoxaemic groups. The slight 
shift in RQ of endotoxaemic rats at later time points could reflect a minor shift in the 
balance of substrate oxidation towards carbohydrate oxidation.
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The cage temperature remained at around 23°C throughout all the experiments, 
below the range of thermoneutrality for rats of this age. To maintain body temperature 
rats respond by facultative thermogenesis and by behavioural adaptations such as 
huddling. Uncontrolled heat loss in these animals was minimised by allowing the rats 
to suckle with their dams and by measuring five rats together in the indirect calorimetry 
chamber. The causes of hypothermia in the endotoxic animals could be due to 
increased vasodilation, decreasing huddling behaviour and increasing heat losses. 
However, the strong correlation between rectal temperatures and VO2 suggest that 
thermogenesis itself is involved in the mechanism of hypothermia in the animals.
Inhibition of the proton leak across the inner mitochondrial membrane could be 
a factor contributing to hypometabolism in this model and it is possible that UCP2 is 
involved in this response to sepsis. Under basal conditions the proton leak represents 
up to 20-40% of tissue VO2 in rodents10. The magnitude o f temperature decline and 
drop in VO2 caused by endotoxaemia appears too large to be accounted for by the 
proton leak alone and it likely that other factors are involved. Cytokines, 
prostaglandins, leukotrienes and the vagus nerve have all been implicated in reduced 
thermogenesis observed in endotoxaemia but the physiological basis is still
. • 58;60;61uncertain
It is clear that endotoxaemia induces hypometabolism and hypothermia in 
neonatal rats. However, other workers have suggested an increase in UCP2 expression 
in endotoxaemia, which would be predicted to lead to an increase rather than a decrease 
in energy expenditure. It was therefore decided to determine how these whole body 
changes in resting energy metabolism related to changes in UCP2 expression.
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3. Development of a method for analysis of UCP2 protein
levels in tissues.
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3. Development of a method for analysis of UCP2 protein levels in
tissues.
3.1 Introduction
Most studies o f UCP2 expression rely on Northern Blotting; this technique is 
based on the detection of mRNA message for the UCP2 protein. Northern Blot analysis 
has identified UCP2 mRNA in skeletal muscle, lung, heart, placenta, kidney tissue and 
throughout the immune system 21. Reports have indicated that expression of this protein 
occurs in response to mediators of the immune system such as TNFa and under 
conditions of enhanced fatty acid oxidation 43>62’63. Tissue specific expression has been 
demonstrated with UCP2 up-regulation occurring in the liver during hepatic steatosis 
and in skeletal muscle upon TNFa administration. Induction o f UCP2 expression has
9 calso been described during sepsis , although this may reflect macrophage infiltration 
into the tissues of these organs. However, mRNA expression is not always indicative of
f r o  M
protein expression, therefore conclusions about a proteins function drawn^ymRNA data 
alone can be flawed. The aim of the work described in this study was to develop a 
method to determine UCP2 protein expression in a neonatal model o f sepsis in order to 
clarify the relationship between UCP2 protein and whole body metabolism.
In neonatal animal models, sepsis has been associated with a significant 
decrease in core body temperature and a reduction of the proton leak in hepatocytes7. If 
UCP2 protein expression is up-regulated during sepsis then this is at odds with its 
supposed role in thermogenesis.
Protein expression is commonly studied by Western blotting, a powerful 
technique that can separate a protein by means of its molecular weight and detect it by 
antibody recognition. Good results rely on successfully separating a sample by mass, 
(SDS-PAGE) and then detecting the protein specifically in an immunoassay step.
This chapter describes the development o f a protocol for UCP2 western 
blotting. As a positive control for UCP2 was not available in initial experiments, SDS- 
PAGE separations were optimised using SCHAD, a protein o f similar molecular 
weight. Only once a control for UCP2 was obtained was it possible to optimise the
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protocol to detect in vivo levels of UCP2 protein expression. With this done we went on 
to identity the pattern of UCP2 expression in rat pups and decide in which tissues this 
expression would be studied to determine the effects of sepsis. Finally I present the 
rationale and methods for normalising the level of expression between samples.
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3.2. Methods
3.2.1. Animals
Animals from the indirect calorimetry experiments were used as the source of 
all materials for these experiments. 11-13 day old rat pups were weighed and their 
rectal temperature were taken before receiving either intraperitoneal saline or 
Endotoxin, 300pg/g Lipopolysaccharide (LPS; E.coli 055:B5, Sigma, Poole, Dorset, 
U.K). The rat pups were placed with mother and monitored for a 2hr or 6hr time period, 
weighing at hourly intervals to assess whether dehydration was occurring. The pups 
were then blind assessed for signs o f sepsis using a scoring system adapted for rat pups7 
from a system for adult rats64 (see chapter 2). Rats that had been injected with LPS and 
did not become endotoxic were culled and not analysed.
3.2.2. Sample Preparation
Tissues were quickly removed, finely chopped and washed ice cold Medium B 
(2mM Hepes, 250mM Sucrose, 0.1 mM EGTA, pH 7.4 (plus 1% BSA to bind lipids)) 
and homogenised at a tissue weight to medium volume of approximately 1:2 using a 
hand held glass homogeniser. Homogenate was kept on ice before isolating 
mitochondria or stored at -20 °C.
3.2.3. Mitochondria
Methods from paper by Eaton et al, 199465 \The homogenate was centrifuged at 
1047 x g  at 4°C for 10 minutes (Sorral Super T-21, SL50T rotor). After this the 
supernatant was retained and the pellet was re-suspended in Medium B, and re­
centrifuged at 1047 x g  at 4°C for 10 minutes and the supernatant was retained. The 
supernatants were combined and then centrifuged at 11621 x g  at 4°C for 10 minutes. 
This mitochondrial pellet was retained, re-suspended in medium B and centrifuged 
again at 11621 x g  at 4°C for 10 minutes. Finally the pellet was washed in medium B 
by spinning at 11621 x g at 4°c for 10 minutes. This pellet was re-suspended in 300jnl 
o f medium B (without BSA) containing Protease inhibitors including a broad spectrum 
of serine, cysteine and metalloproteases and calpains diluted in accordance with
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manufacturers’ directions (Complete-mini Protease Inhibitors, Roche). The sample was 
stored at -20°C.
3.2.4. Mitochondrial Membranes
Mitochondria obtained as above were re-suspended in 20-mM potassium 
phosphate buffer pH 7.2 containing 0.3 mM KC1 and Phenylmethylsulphonylfluoride 
PMSF (0.1 mg/ml) and sonicated on ice with a probe sonicator. Sonication was carried 
out 8 times for 15 seconds at lOpM amplitude, with 15 second cooling periods in 
between. The sample was then centrifuged at 111500 x g  (Sorral Super T-21, SL50T 
rotor) for 40 minutes, the supernatant was discarded and pellet re-suspended in 
phosphate/KCL/PMSF buffer. The centrifugation and re-suspension process was 
repeated twice and the final pellet was re-suspended in a minimum volume of the same 
buffer containing protease inhibitors and stored frozen at -20°C. Methods adapted from 
Ghadiminejad et al, 199066.
3.2.5. Standard Gel electrophoresis
Samples were heated at 95°C for 5 minutes with loading buffer (3pg 
Bromophenol Blue, 0.03 lg  Dithiothreitol (DTT), 4% SDS, 25% glycerol, 0.25 M Tris 
/HCL, ph 6.8, Made up in distilled water to a volume o f 20ml and stored in 1 ml 
aliquots at -20°C), (1/1 v/v), and loaded onto a 12 x 12cm, 12% SDS-polyacrylamide 
gel. Samples were run at 20V, increasing to 100V, over 5 hours in running buffer 
(14.85g glycine, 3.78g Tris base in 1 litre o f distilled water) with a constant current of 
30mA per gel. The separated proteins were then transferred, by electroblotting, to a 
membrane (Hybond™- C Extra Amersham Pharmacia,) using a Hoefer electrophoretic 
transfer cell for 2 hours at 100V in running buffer containing 20% methanol, chilled by 
passing cold water round a water junket.
Total protein content could now be visualised by silver staining using the 
methods described.
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3.2.5.1 Silver Staining67
The gel was placed in 200ml of fixing reagent (40% Ethanol/ 10% Acetic acid) 
for 10 minutes, rinsed in 200ml of distilled water for 10 minutes and placed in 100ml 
fix/sensitising solution (0.05% Glutaldehyde, 0.0037% Formaldehyde, 40% Ethanol) 
for 5 minutes. It was then rinsed in 200ml 40% Ethanol for 20 minutes, followed by 
200ml of distilled water for a further 20 minutes, before being placed in sensitising 
reagent (0.2% sodium thiosulphate) for 1 minute. The gel was then rinsed with two, 1 
minute washes with 200ml distilled water and placed in 100ml 0.1% silver nitrate 
solution for 20 minutes. The gel was then rinsed for 1 minute with 200ml o f distilled 
water and then placed in 100ml of developing solution (5.0g o f sodium carbonate 
dissolved in 200ml of distilled water containing 40pi o f formaldehyde). This solution 
was replaced with fresh developing solution after approximately 1 minute and the gel 
was developed until the required degree of staining was obtained (approximately 15 
minutes). The reaction was stopped in 5% Acetic acid for 5 minutes. Wet gels were 
stored in 0.03% sodium carbonate and sealed in plastic.
3.2.6 Standard Western Blotting
After protein transfer, the membrane was blocked for 1 hour at room 
temperature in block buffer (2.42 Tris base, 8g sodium chloride, 3.8ml 1M 
hydrochloric acid and 500 pi Tween-20 dissolved in 1 litre distilled water containing, 
5% Marvel™ non fat dried milk protein). The membrane was then exposed overnight at 
4°C to a primary antibody diluted to an appropriate concentration in block buffer, 
washed several times for 10 minute periods with wash buffer (2.42g Tris base, 8g 
sodium chloride, 3.8ml 1M hydrochloric acid and 5ml Tween-20 diluted to 1 litre in 
distilled water) and incubated for 1 hour at room temperature with an appropriate 
alkaline peroxidase-conjugated secondary antibody diluted to the stated concentration 
in block buffer. The membrane was then washed several times with wash buffer before 
the appropriate detection step.
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3.2.7. Detection
Detection was by either diaminobenzidine (DAB) (Novocastra Laboratories 
Ltd) or ECL+ (Amersham Pharmacia) substrate and performed according to the 
manufacturers instructions described below.
3.2.7.1. DAB.
One DAB tablet was dissolved in 10ml of TBS, pH 7.6 (2.42g Tris base, 8g 
sodium chloride and 3.8ml 1M hydrochloric acid diluted to 1 litre in distilled water). In 
a separate tube 0.2ml hydrogen peroxide (30% w/v) was added to 5.8ml distilled water. 
0.2ml of this diluted hydrogen peroxide solution was added to the dissolved DAB 
solution. The solution was mixed well and then applied directly to the pre-wetted 
membrane. Bound peroxidase gave rise to an insoluble brown staining which got 
progressively stronger over time. To obtain the maximum signal to noise ratio the 
reaction was observed carefully and stopped at an appropriate time 5-10 minutes after 
exposure, by washing thoroughly with distilled water.
3.2.7.2 Chemiluminescence detection.
Detection solutions A and B were mixed in a 40:1 ratio. The final volume of
-y
detection reagent required was 0.1 ml/cm of membrane. Any excess buffer from the 
final washing step was drained from the membrane and it was placed protein side up on 
a sheet of Saran Wrap™. The mixed detection solution was applied to the membrane 
and it was incubated at room temperature for 5 minutes. The membrane was drained of 
excess detection solution and placed protein side down onto a fresh piece o f Saran 
Wrap and carefully wrapped up, gently smoothing out any air bubbles. The wrapped 
membrane was then placed protein side up in an X-ray film cassette. A sheet of 
autoradiography film (Biomax MR, Kodak ) was placed onto the membrane and the 
film was exposed for a designated period o f time ( 1 - 2 0  minutes)
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3.2.8. Western blotting adaptations
3.2.8.1 SC HAD
For SCHAD Western blotting, electrophoresis and blotting was performed as 
described (3.2.5, 3.2.6). The membrane was exposed, first to an anti-SCHAD antibody 
for 1 hour at room temperature at concentration o f 1:1000 in blocking buffer. After the 
washing step the membrane was then exposed to the secondary antibody for 1 hour at 
room temperature at a concentration of 1:1,000 (and 1:20,000 after optimisation) in 
block buffer before the detection step with DAB or ECL+
3.2.8.2 UCP2
Electrophoresis was performed as before (3.2.5). However, SDS was not used in 
the transfer buffer. The Primary antibody, either Santa Cruz (Santa Cruz 
Biotechnology, Inc. Affinity-purified goat polyclonal antibody raised against a 34 
amino acid peptide mapping at the amino terminus of uncoupling protein 2 of human 
origin) or Calbiochem (Affinity purified rabbit polyclonal antibody raised to an epitope 
representing amino acids 144-157 of mouse UCP2) was incubated overnight at 4°C in 
the stated concentrations diluted in block buffer (optimised method used 1:1000) The 
membrane was then washed several times and then incubated for 1 hour at room 
temperature with an alkaline peroxidase conjugated polyclonal anti rabbit antibody 
(Calbiochem) at a 1:2500 concentration in block buffer. The membrane was washed 
again before the detection step with ECL+ or DAB substrate.
3.2.8.3. Citrate Synthase
Electrophoresis and blotting was performed as in the standard protocol 
described. Polyclonal antibody raised to porcine citrate synthase (Immune Systems 
Ltd.) was applied to the membrane at the described concentrations for 1 hour at room 
temperature. The membrane wash washed with wash buffer and then incubated with an 
alkaline peroxidase conjugated monoclonal anti mouse antibody at the stated 
concentrations for 1 hour at room temperature. The membrane was then washed several 
times with wash buffer before the detection step with ECL+ (Amersham Pharmacia)
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3.2.9. Dot Blots
Dot blots are a quick and effective method of determining the optimum 
antibody dilutions for a Western blot.
One dot blot was prepared for each combination o f antibody concentrations 
tested. They were prepared by spotting a suitable amount o f protein directly onto the 
membrane pre wetted according to the manufacturer’s recommendations. The dot blots 
were air-dried and then re wetted before blocking for 1 hour with block buffer at room 
temperature. The blots were then washed in wash buffer for five, x five minute periods, 
changing the buffer each time. The blots were then incubated individually with the 
designated concentration of primary antibody diluted in block buffer for 1 hour at room 
temperature. The blots were washed in wash buffer as before and then incubated 
individually with the designated concentration o f secondary antibody for 1 hour at 
room temperature. The blots were washed again and finally incubated in ECL+ 
detection reagents and exposed to Biomax MR Kodak film according to the 
manufacturer’s instructions. The results were then assessed for the strongest true 
positive and lowest false positive and background reactivity.
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3.3 Results
3.3.1. Gel Composition
Gel Electrophoresis is a method by which a sample can be separated into its 
protein components based on their molecular weight. The primary objective was to 
determine the composition of gel that would resolve within a molecular weight range 
comparable to that o f UCP2.
As at this stage no UCP2 control was available, protein standards o f comparable 
molecular weight to UCP2 were run with other standards o f varying molecular weight 
on a 10% acrylamide gel and silver stained (See methods section 3.2.6.1) (Figure 3.1)
1 2  3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 3.1. Electrophoresis of standard proteins on a 10% acrylamide gel. Standards included; 
Cytochrome C reductase 1, 2 and 3 at 50, 10 and 5 pi, Creatine phosphokinase (43kDa) 4,5,6, Short 
chain 3-hydroxyl- acyl-CoA dehydrogenase (33kDa) 7,8,9 Cytochrome c (12kDa) 10,11,12, and Bovine 
serum albumin (BSA) (68kDa) 13,14,15 at levels of 1,5 and 10 pi respectively.
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The molecular mass o f UCP2 is 32kDa, close to that o f SCHAD. SCHAD ran 
far too close to the solvent front so it was decided to use a 12 % acrylamide gel instead.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 3.2. Electrophoresis of protein standards on a 12 % acrylamide gel. Standards included: BSA 
(68kDa) 1,2,3, Cytochrome C (12kDa) 4,5,6, short chain hydroxacyl-CoA dehydrogenase (33kDa) 7,8,9, 
Creatine phosphokinase (43kDa) 10,11,12, at levels of 1, 5, and 10 pi respectively. Cytochrome 
reductase 13, 14 15 was applied at 50, 10 and 5pl.
12 % acrylamide gels were found to be suitable for resolving proteins of 
comparable molecular weights to UCP2. UCP2 is a membrane bound protein and 
isolation and identification from mitochondrial preparations based on molecular weight 
alone would prove difficult. The next stage was to attempt to identify UCP2 by 
immunoblotting the mitochondrial proteins separated on the gel. UCP2 protein 
standards are not commercially available and optimising the western blot system 
proved difficult without a protein standard.
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UCP2 expression was initially reported to be constitutively expressed in liver 
mitochondria. It was thought that preparations o f this kind might be useful as a native, 
high titre, sample.
3.3.2. Western Blotting
As no UCP2 protein control was available the Western blotting system was 
initially optimised for SCHAD. SCHAD is a stable mitochondrial protein with a similar 
molecular weight to UCP2, in dual blots for UCP2 and SCHAD it was to provide an 
internal control for the relative amount of mitochondrial protein loaded in each sample.
3.3.3. Optimising western blotting fo r  SCHAD
Protein standards, mitochondrial samples and bovine and porcine SCHAD 
controls were separated on a 12% polyacrlyamide gel before blotting as described in 
section 3.2.8.2. Buffer solutions, antibody concentration and incubation periods were 
all optimised by a series of dot blot experiments and the detection limit of DAB and 
ECL+ were described by serial titration o f the SCHAD controls and sample 
preparations. Silver staining the gel after the transfer procedure confirmed good 
transfer o f protein from the gel to the membrane
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3.3.4. Antibody Concentration (Dot blot)
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Figure 3.3. Results of a Dot blot assay. Control and positive native samples were applied to strips of 
membrane and then incubated with differing concentrations of primary and secondary antibodies. The 
antibody concentrations that gave the clearest positive results with ECL detection were chosen for future 
western blot incubation.
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Strip h gave the best result, both in clarity and in minimal amount of primary 
antibody (Figure 3.3). These concentrations were adopted for all future SCHAD 
western blotting experiments
3.3.5. Determining Detection limits
DAB solution on hydrobond membrane ECL+ detection developed on X-film
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Figure 3.4. Determining the detection limits of SCHAD western blotting. Porcine and bovine 
SCHAD control were run on a gel at dilutions of 1/100-1/20,000
To determine the detection limit o f the ECL and DAB substrate systems, bovine
and porcine controls were loaded onto gels at serial dilutions from 1:1000 to 1: 20,000.
The DAB substrate system indicated a positive result by a dark grey precipitate directly
on the membrane, whereas ECL induced fluorescence o f positives had to be developed
in the darkroom on MR Kodak film. Dab substrate detection limit was at a 1/1000
20,000
dilution whereas ECL s’ detection limit was at 1/1-00,000 (Figure.3.4)
As UCP2 is expressed at low levels, it is important to obtain maximum 
sensitivity. The DAB substrate system was a simple procedure but did not have the 
sensitivity, or the flexibility to study a range o f exposure times o f the ECL+ system. 
Future studies concentrated on ECL+ detection
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3.3.6. Comparing standard and optimised SCHAD western blotting
Figure 3.5. Before (A) and After (B) SCHAD Western Blot Optimisation: Porcine and bovine 
controls were loaded at 1:5000 dilution, liver homogenate at -30  ng and liver mitochondria were loaded 
at ~5ng and ~10ng. Samples for both (A) and (B) were from the same stock solutions kept at -20°C
To investigate the overall effect of the optimisation process dual blots of control 
and laboratory prepared samples were prepared and developed using the standard and 
optimised procedure. The improvement made by adjusted the standard procedure was 
clear (Figure 3.5).
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3.3.7. Optimising Western Blotting fo r  UCP2
Initial western blots for UCP2 in liver homogenate were carried out using the
specification established for SCHAD western blotting. These were completely
unsuccessful. Each step of the western blotting was reconsidered for optimisation. SDS 
*Vor*\
was removed the transfer buffer as it can reduce the stringency of binding of some 
proteins (as advised by Stuart, JA), other blocking agents and protocols were 
considered, washing time was extended and chessboard dot blot assays were used to 
determine optimal antibody concentrations and incubation periods.
3.3.8. Cross reactivity.
Blots had high background interference with multiple banding patterns and gave 
false positive results to purified SCHAD controls. The cross reactivity of the primary 
antibody (Santa Cruz) was confirmed by further dot blot assays (Figure 3.6). It is 
interesting to note the dark ring around the perimeter o f the liver homogenate blot. 
UCP2 protein is reportedly expressed in Kupffer cells in the liver63. Dot blotting onto 
the membrane could by some chromatographic effect, separate the kupffer fraction of 
the liver homogenate. The cross reactivity to SCHAD protein would question the 
reliability o f any UCP2 western blotting data obtained with this antibody. However, an 
alternative explanation could be due to the presence of UCP2 in purified SCHAD. This 
is thought to be unlikely due to the low amount o f UCP2 in heart tissue, the source of 
purified SCHAD.
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Figure 3.6. Cross reactivity of UCP2 antibody. Dot blot for UCP2 (antibody concentrations l°Ab 
1:500, 2°Ab 1:1000). Samples include SCHAD controls Mitochondrial preparations from Liver and 
White Adipose Tissue (WAT) homogenate and homogenate from muscle and liver tissue. Dark image on 
film indicates positive reaction. SCHAD control reacts strongly to ECL+ reagent when incubated with 
UCP2 antibody.
The specificity of the Santa Cruz antibody was compared to a UCP2 antibody 
from Calbiochem. Dot blots probed with the Calbiochem antibody, unlike Santa Cruz 
probed blots, did not give positive reactions to either SCHAD or liver homogenate 
(Figure 3.7). Further investigations with the Santa Cruz antibody were abandoned in 
favour of the Calbiochem Antibody.
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Figure 3.7. Comparing Santa Cruz and Calbiochem UCP2 Antibody. 3pl aliquots of liver 
homogenate, liver mitochondria and porcine SCHAD control were applied to each piece of membrane. 
After allowing drying the membranes were probed with the stated concentration of primary and 
secondary antibody. Blots were developed on Film using ECL+ detection system.
The lack of a proper control for UCP2 protein was a significant problem to 
optimising the system. In an attempt to obtain high UCP2 titre samples mitochondrial 
preparations were fractionated to isolate the supposed UCP2 rich inner membrane 
(method section 3.2.4.). These blots were unclear, the liver mitochondria did not seem 
to provide a source of high concentration UCP2 protein. Western blots of these samples 
for UCP2 did not give rise to distinct bands at a position comparable to 32Kda and 
Maldi-tof analysis of the silver stain band at this position established by molecular 
weight markers were not successful in identifying UCP2 protein.
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Although initially, UCP2 was described as being present in hepatocytes62, 
whilst this work was being undertaken other studies determined that the apparent UCP2 
expression in hepatocytes is due to low level expression in Kuppfer cells63. It is likely 
there are many other be proteins or fragments other than UCP2 within a mitochondrial 
membrane fraction at 32Kda, that would mask the presence of UCP2 particularly if 
UCP2 protein is expressed at the low levels described by Stuart et al 33. It was not 
possible to optimise the system for UCP2 western blotting until a control (UCP2 
protein raised by heterologous expression in E.coli) was made available (kind gift Jeff 
Stuart, University of Cambridge)
Figure 3.8. Titration of UCP2 Control. UCP2 control loaded onto gel at eoncontrations of t /500, 2»\a,
t|*4  ^ 0 -25rv .  0 ' l l5 > v .  J
U1Q0Q, 1/2QQ0, 174000, 176000, 1/8000. Western blotting with in house method (Antibody 
concentration: l°Ab, 1:1000, 2°Ab, 1:2500) film exposed for 5 min.
Once a control for UCP2 had been obtained it was possible to optimise the 
western blotting procedure and establish the expression pattern for this protein in our 
model (see Figure 3.8 for an optimised western blot of different dilutions of the UCP2 
control).
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3.3.9. Sample Choice
UCP2 western blotting was applied to a wide range of mitochondrial samples 
from rat pups (see Figure 3.9). The clearest positive results were obtained with those 
samples prepared from lung and spleen. Other tissues, including the liver did show 
some faint reactivity towards the UCP2 antibody. However studies with UCP2 
knockout mice suggested that this reactivity was likely to be due to a lack o f antibody 
specificity rather than the presence of UCP2 protein 44.
Further studies with UCP2 concentrated on determining the level o f UCP2 
protein expression in the lung and spleen in septic and control rat models of neonatal 
sepsis.
A
Figure 3.9. UCP2 western blot sample range. Mitochondrial preparations from each tissue were loaded 
at (~30ng, 12.5pi volume) and tested for UCP2 reactivity. Tissues were taken from 11-13 day old rats 
unless stated Ad. (adult) Western blotting was performed following the in house protocol. Films were 
exposed for 5mins (A) and 20 mins (B)
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Mitochondrial preparations of the lung and spleen tissue harvested from our 
control and endotoxic rat pups were subject to UCP2 western blot analysis. Lung and 
spleen samples were run on dual gels and the respective UCP2 band densities were 
analysed pair-wise, control vs. endotoxaemia.
Using the described protocol for UCP2 western blotting we obtained reasonable 
blots with low background and a clear band in a position comparing well to the 
molecular weight of UCP2 and to the UCP2 standard (see Figure 3.10).
Figure 3.10. Optimised UCP2 western blotting. Spleen and lung mitochondria were prepared from 
endotoxic (E) and control rat pups (C) (see methods section) and loaded in 12.5pl aliquots. Samples were 
western blotted with UCP2 controls at the stated concentrations and results were developed on Biomax 
MR Kodak films using ECL+ (Amersham Pharmacia).
From these western blots we could compare the levels of UCP2 protein 
expression between samples by comparing their band densities using a densitometry 
programme (Scion image, Beta version 4.0.2). Running respective sets of control and 
endotoxic samples together on the same gel and then analysing them pair-wise 
eliminated gel to gel differences. This did not eliminate differences that could exist in
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the relative levels o f mitochondrial protein between samples. For this other controls 
were needed.
3.3.10. Controls
When analysing protein expression of a mitochondrial protein it is not enough 
to normalise just for total protein content. Two samples may have the same total protein 
content but this does not mean they have the same amount o f mitochondrial protein, 
even when the samples have been prepared in the same way. UCP2 is localised to the 
inner mitochondria membrane. Comparative analyses of control and endotoxic samples 
needed standardisation by a factor that would remain stable during endotoxaemia and 
indicate the relative mitochondrial content.
Citrate synthase is commonly used as measure for mitochondrial content as it is 
a mitochondrial matrix protein that should not be affected by sepsis. It has an important 
role in mitochondrial function as it catalyses the first step o f the Krebs cycle, the 
condensation of oxaloacetate and acetyl CoA to Citrate and CoA. The standard citrate 
synthase assay relies on a secondary reaction o f the side product CoA with dithio-1,4- 
nitrobezoic acid (DTNB). The coloured product, 2-nitro-5-thio benzoic acid (NTB) is 
then used to calculate the activity of citrate synthase (see methods 3.2.8.3).
Together with a standard citrate synthase assay, it was thought it would be 
useful to develop a citrate synthase western blot. As citrate synthase has a molecular 
weight of ~ 52kDa it was thought possible to measure expression levels of citrate 
synthase on the same blot as UCP2, therefore providing an on gel standard for the level 
of mitochondrial protein.
It was envisaged that mitochondrial samples, plus appropriate controls for 
UCP2 and citrate synthase, could be run following the in house protocol for UCP2 
western blotting. Once separated by electrophoresis and transferred, the membrane 
would then be divided into UCP2 and Citrate synthase reactive sections that could be 
probed with the appropriate antibody.
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Unfortunately, the only commercially available antibodies for citrate synthase 
was raised against pig heart citrate synthase and did not cross react with rat citrate 
synthase (see Figure 3.11).
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Figure 3.11. Western Blotting for Citrate Synthase. Spleen and Lung mitochondria were loaded as 
for UCP2 blotting and run with porcine heart Citrate synthase controls (at 5, 10 and 20pg). After 
electrophoresis and transfer, the resulting membrane was probed with Citrate synthase Antibody 
(Immune Systems Ltd).
Mitochondrial samples were standardised simply based on the activity of their 
citrate synthase activity.
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3.4 Discussion
This study demonstrated that it was possible to use Western blotting to study the 
expression of UCP2 protein in neonatal rat pups. UCP2 mRNA is reported as being 
extensively expressed in the liver but this does not seem to be translated into protein 
expression. Western blots o f liver mitochondria gave rise to indistinct bands relative to 
the UCP2 control. It has been suggested that this low level reactivity is likely to be due 
to lack of antibody specificity rather than the presence of UCP2 protein44. 
Mitochondrial samples from the lung and spleen both gave rise to distinct bands 
relative to the UCP2 control. A comparative analysis o f UCP2 Western blotting, using 
control and UCP2 knockout mice support these findings and suggest that UCP2 may 
have a role in the immune response.
Studies investigating the level o f expression in these tissues from endotoxic and 
control animals will examine this hypothesis further.
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4. UCP2 Western blotting
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4. UCP2 western blotting
4.1 Introduction
Our investigations with UCP2 western blotting in neonatal rat tissue (chapter 3) 
revealed that a high level expression of UCP2 did not reside in liver tissues as had been 
previously thought. However, there was high expression in tissues that have significant 
populations o f immune cells, such as the lung and spleen. This evidence is supported 
by other western blot investigations of UCP2 expression in adult rats and knock out 
studies of UCP2 in mice, implicating a role for this protein in the regulation of immune 
function44,68.
The uncoupling action of UCP2 is reported to be functionally dependent on the
nn
presence o f an obligatory co-factor, ubiquinone . The primary role o f this compound 
in eukaryotes is to transfer electrons between redox components of the electron 
transport chain and therefore create a proton gradient across the inner mitochondrial 
membrane. Evidence suggests that ubiquinone in mitochondria may be involved in 
ROS production. Its distribution is not limited to mitochondria and in its reduced form, 
ubiquinol, it has been shown to act as an antioxidant against lipid peroxidation69. 
Therefore, in tissues in which UCP2 expression occurs, such as spleen and lung, UCP2 
expression could be co-regulated with levels o f ubiquinone. This situation is 
complicated further by recruitment and movement o f macrophages, which strongly 
express UCP2.
Mitochondria were prepared from lung and spleen from control and endotoxic 
rat pups and analysed for UCP2 expression and ubiquinone levels by western blotting 
and HPLC respectively. Once normalised for mitochondrial content by citrate synthase 
activity, a clearer picture of the relationship o f UCP2 and ubiquinone, with 
endotoxaemia could be established. Our results suggest that UCP2 may be involved 
with macrophage mediated attenuation of ROS as part o f the immune response.
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4.2 Methods
4.2.1. Animals
Animals from the indirect calorimetry experiments (Chapter 2) were used as the 
source for all the materials for these experiments..
4.2.2. Mitochondrial Preparation
Mitochondria were prepared as described previously (section 3.3.2.) from 
control and endotoxic rat pup lung and spleen tissue collected 2 or 6 hours after LPS or 
saline injection. The tissues from each batch of rat pups were pooled so that each 
mitochondrial preparation was from 4-6 rat pups. Samples were then stored at -20°C 
until analysis (within 6 weeks of sample generation).
4.2.3. UCP2 Western Blotting
Proteins were separated by electrophoresis and electro-blotted as described 
previously (Chapter 3). The primary antibody, UCP2 (Calbiochem) was incubated at a 
1:2500 dilution overnight at 4°C. Bound peroxidase conjugated antibody was revealed 
with an enhanced chemiluminescence reagents kit (ECL+, Amersham-Pharmacia 
Biotech) and the results were recorded on Biomax MR Kodak film by a 5 minute 
exposure to the phosphorescing membrane. Films were scanned and the signal was 
quantified using a densitometry programme (Scion image software Beta version 4.0.2). 
For statistical analysis, control and endotoxic samples were compared on the same blot 
only.
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4.2.4. HPLC analysis o f  ubiquinone
To lOOpl of each mitochondrial sample, 900pl o f MilliQ water was added. To 
these samples were added 1ml methanol, 25pl co-enzyme Qs (internal standard) and 
3.9ml rc-hexane. The solution was thoroughly mixed by a bench vortex and left to 
settle. Once the layers had separated, the upper (hexane) layer was removed and 
retained in a clean tube. The bottom layer was re-extracted twice with 4 ml hexane and 
the extracts were combined and blown to dryness under nitrogen. Samples were re­
dissolved in 400 j l x 1 ethanol/methanol ( 1:1) and analysed by HPLC on a Hypersil 50DS 
250mm x 4.6mm Ci8 column (Hypersil, Runcorn, Chesire) using a gradient of 60 to 
86% ethanol (containing 50mM NaC1 0 4 ) against methanol containing 50 mM NaC1 0 4  
over 20 minutes. Quantification was on the basis o f the absorption of oxidised 
coenzyme Q at 275nm with reference to the internal standard; recovery was 63 ± 5 % 
(mean±SEM).
4.2.5. Citrate synthase Assay
965pl Tris HCL (pH 8.0), lOpl, 5pM acetyl CoA, lOpl lOmM DTNB (Sigma), 
lOpl Triton-X (Sigma) and lOpl o f each mitochondria sample(l:100 diluted in double 
distilled H2O) were combined in a cuvette, placed in a spectrophotometer and allowed 
to run to baseline at 37.5°C, 412nm absorption. Once a stable baseline was obtained, 
5pi o f 50mM sodium oxaloacetate pH 8.0 (freshly prepared) was added and the sample 
measured continuously for 5 minutes. Once recording had finished appropriate 
graphical co-ordinates were set to calculate the rate o f 2-nitro-5thio benzoic acid (NTB) 
formation from DTNB and thus the activity of citrate synthase.
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Figure 4.1. C itrate synthase assay trace. Addition of oxaloacetate permits the formation of CoA from 
Acetyl-CoA. Citrate synthase present in the mitochondrial sample then catalyses formation of the 
coloured NTB from DTNB and CoA.
4.2.6. Protein Assay
Protein levels were quantified using the Folin-Ciocalteu reagent method as 
described by Peterson et al
Solutions;
(i) Copper-tartrate-carbonate (CTC). 0.1% copper sulphate (pentahydrate), 0.2% 
potassium tartrate, 10% sodium carbonate.
(ii) 10% Sodium dodecyl sulfate (SDS)
(iii) 0.8 N Sodium hydroxide
Reagent A: Solutions i, ii and iii diluted in distilled water at a 1:1:1:1 ratio.
Reagent B: Folin-Ciocalteu phenol reagent (Fisher Scientific (2N)) diluted at a 1:5 ratio 
with distilled water.
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A ten step dilution series o f a 200pg/ml stock o f bovine serum albumin (BSA) 
was prepared in distilled water to give a range of 2-20pg in 4.5ml cuvettes. Three step 
dilutions were prepared from each sample using 5, 10 and 20pl o f a 1:100 dilution of 
the sample made up to a total volume of 1ml in distilled water in 4.5 ml cuvettes. 1 ml 
of Reagent A was added to each prepared cuvette. These were then mixed thoroughly 
and allowed to stand at room temperature. After 10 minutes, 0.5ml of reagent B was 
added and thoroughly mixed in each cuvette. Samples were left for another 30 minutes 
at room temperature. Absorbance was read at 720nm. Total protein content was 
calculated using linear regression of the BSA standard curve (range 0-20pg) (see figure 
4.2). Unknowns were calculated by interpolation on this standard curve for each 
sample. Standards were always analysed with each set o f samples.
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Figure 4.2 Protein assay trace. Chart displays a standard curve for BSA, from which the values for 
approximate protein content of each sample could be calculated.
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4.3 Results
4.3.1 Normalisation o f  data
SDS PAGE electrophoresis and electroblotting are complicated multi-step 
procedures. A slight difference at any stage can have an impact on the final result. To 
minimise gel-to-gel differences, each step was carefully optimised and in each 
experiment all procedures were carried out to the set standards. To ensure gel to gel 
differences did not affect results, samples were only compared on the same blot, i.e. 
date matched control and endotoxic samples were run together and compared against 
one another.
Using the described protocol, the difference in the level o f UCP2 protein
between samples could be detected as a difference in band density. It was important
qiAAAfcijtal
that this difference was qualified by normalising for total mitochondrial content. Band 
density was normalised to citrate synthase, a commonly used measure for 
mitochondrial content. The level of this mitochondrial matrix protein is thought not to 
be affected by sepsis, to ensure that this was the case we compared the level of citrate 
synthase, normalised for total protein content, between the control and endotoxic 
samples for each type o f mitochondrial preparation.
There are many factors that can alter the level of citrate synthase and total 
protein content in an individual mitochondrial preparation. However, it is reasonable to 
assume that by following the same protocol, the range of values for each type of 
preparation will be normally distributed within a certain range. There was no 
significant difference in the value for the level of citrate synthase activity per mg/eeA of 
total protein between control and septic samples from each type of mitochondrial 
preparation (Figure 4.3). This suggests that citrate synthase levels were not affected by 
endotoxaemia and that it was a suitable control for mitochondrial protein content.
75
Spleen C Spleen S
6hr 6hrs
Spleen E Lung C Lung E 
2hrs 6hr 6hrs
Sample source
Lung E Spleen C
2hrs 2hrs
Figure 4.3. Comparing the level of citrate synthase activity per mg/wl of the total protein content 
between mitochondria isolated from endotoxic and control ra t pups. There was no significant 
difference in this value between control and septic samples from each type of mitochondrial preparation. 
For samples from rat pups culled 2 hours after LPS or saline injection n=16. For samples from rat pups 
culled 6 hours after LPS or saline injection n=10. Results expressed as mean ± SEM
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4.3.2. UCP2 Western Blotting
Results are presented as mean ± SEM for each type of mitochondrial 
preparation. Although this gives us an idea of the comparative expression of UCP2 
between different types of mitochondrial preparations it does not take into account the 
effect that gel-to-gel differences may have on the results. This is likely to be great as 
densitometry is very dependent on the film background and precise exposures etc. 
Control and endotoxic samples from the same litter o f rats were run together on the 
same gel and these results were analysed by paired t-test to identify the significance of 
any differences between sample types and decrease variation due to gel to gel 
differences.
When comparing mitochondrial samples from rat pups culled 2 hours after 
injection (Figure 4.2 A) we found a significant difference in Band density / mU citrate 
synthase between samples from control and endotoxic rat pups. UCP2 protein 
expression was increased in mitochondrial preparations from lung tissue during 
endotoxaemia (p value <0.05). There was no significant difference in UCP2 expression 
between control and endotoxic spleen samples (p value >0.05)
Similarly, results of mitochondrial preparations from rat pups culled 6  hours 
after LPS or saline injection (Figure 4.4 B), suggest that UCP2 expression in spleen 
mitochondria is unaffected by endotoxaemia. Although there had been an increase in 
UCP2 expression at 2 hours in lung caused by endotoxaemia, this difference was no 
longer significant at 6  hours (p value >0.05). Unfortunately levels of UCP2 expression 
cannot be compared between 2  and 6  hours as the samples were run on different gels.
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Figure 4.4. UCP2 protein expressed in lung and spleen mitochondria from control and endotoxic 
rat pups. The level of UCP2 protein was qualified by band density and normalised for total 
mitochondrial protein content by the activity of citrate synthase. Results are displayed as mean ± SEM 
for each type of mitochondrial preparation. (A) displays the results o f mitochondrial preparations from 
rat pups culled 2 hours after LPS and saline injection (n=16). (B) displays results of mitochondrial 
preparations from rat pups culled 6 hours after LPS and saline injection (n=10). Results are displayed as 
mean ± SEM.
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4.3.3. Ubiquinone
It has been suggested that ubiquinone is an essential co-factor for the activity of 
UCP237. To investigate this relationship further, we studied the amount of ubiquinone 
that existed within each mitochondrial preparation.
Ubiquinone can exist in a number of forms, each o f these are classified based on 
the number of isoprenoid units in their hydrophobic side chain. The commonest forms 
of ubiquinone that exist in the mammalian body have 9 or 10 isoprenoid units and are 
known as Ubiquinone 9 and 10 (UQ9 and UQ 10). Rats have UQ9 predominantly, 
whereas in humans U Q 10 predominates. We analysed each o f mitochondrial samples 
for these isoforms by HPLC. The results were normalised for total mitochondrial 
content by citrate synthase activity and are presented as mean ± SEM for each type of 
mitochondrial preparation. (Figure 4.5 and 4.6)
Comparing the sample means of each type of mitochondrial preparation from 
rat pups culled 2 hours after LPS and saline injection, suggests that there w)(ere no 
significant differences between control and endotoxic mitochondria for either UQ9 or
UQ 10.
The sample means of mitochondrial preparations isolated from rat pups culled 6  
hours after LPS and saline injection indicate that sepsis caused a decrease in the level 
of U Q 10 in lung and spleen mitochondria and in UQ 9 in lung mitochondria. There was 
also a slight increase in the level o f UQ 10 o f spleen mitochondria when compared to 
control. However, the only significant difference found between paired samples was the 
level o f UQ 9 in mitochondrial preparations isolated from control and endotoxic rat pups
When compared to samples prepared from spleen tissue, those from lung tissues 
seem to have a higher level o f UQ9 . The difference in UQ9/UQ 10 ratio between these 
samples may reflect the functional differences between lung and spleen tissue.
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Figure 4.5. Com paring the UQ9/UQ i0 ratio between lung and spleen samples. Values are expressed 
as mean±SEM. Chart ^  presents the results after a 2hr exposure to LPS and Chart presents that after a 
6hr exposure.
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Figure 4.6. Comparing the levels of UQ9 and UQ]0 between control and endotoxic mitochondrial 
preparations from lung and spleen tissue after a 2hr exposure to LPS. The ubiquinone content of 
each mitochondrial preparation was assessed by HPLC and then normalised for total mitochondrial 
content by citrate synthase activity. The relative level of UQ9 and UQio are presented in chart A and B 
respectively. Results for each type of mitochondrial preparation are displayed as average ±SEM. (n=16)
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Figure 4.7. Levels of UQ9 and UQioin control and endotoxic mitochondrial preparations from lung 
and spleen tissue after a 6hr exposure to LPS. The ubiquinone content of each mitochondrial 
preparation was assessed by HPLC and then normalised for total mitochondrial protein content by citrate 
synthase activity. The relative level of UQ9 and UQi0 are presented in (A) and (B) respectively. Results 
for each type of mitochondrial preparation are displayed as average ±SEM. (n=T0)
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4.4 Discussion
LPS-induced expression of UCP2 protein in specific organs has been described
zo # t
previously . UCP2 protein expression was shown to increase 12 fold in lung 
mitochondria 14 hours after LPS injection when compared to controls. No change in 
UCP2 expression was reported in stomach, liver, duodenum, kidney, heart, muscle or
zro
spleen o f the LPS injected adult mice . The results from our study with neonatal rats 
are similar, although the magnitude of the change is much smaller. The only 
statistically significant difference between control and endotoxic samples was found in 
preparations from lung mitochondria. In samples taken from rat pups culled 2 hours 
after LPS and saline injection UCP2 protein expression was increased in lung 
mitochondrial preparations from endotoxic rats when compared to control. UCP2 
protein expression was unaffected by LPS in mitochondrial preparations from the 
spleen. It is interesting that this effect o f LPS on UCP2 expression in lung mitochondria 
occurs so early after LPS injection and that it seems to be diminished 6  hours after LPS 
injection, although it is possible that more samples should have been analysed. It would 
also have been interesting to observe later time points in the suckling rats, although 
mortality is significant at 6  hours.
A previous western blotting study found that significant differences in the level 
of UCP2 protein expression between control and septic samples were not evident until
z o
10 hours after LPS injection . It was suggested that the kinetics of the induction of 
UCP2 protein after LPS injection were consistent with a primary immune response 
leading to oxidative burst in lung. LPS has been reported to activate macrophage 
receptors that stimulate the production of proinflammatory cytokines, eventually
7 0leading to an increase in intracellular ROS . It has been proposed that increased 
intracellular ROS causes an upregulation of the translation o f the large pool of UCP2 
mRNA already present in lung mitochondria. The lung is constantly exposed to toxic 
compounds and pathogens. An induction of UCP2 protein expression by LPS exposure 
in the lung fits well with the hypothesis that UCP2 might function to protect an 
organism from oxidative stress. However, there are considerable difficulties in 
comparing studies made using different models of endotoxaemia.
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It is unlikely that our results reflect an LPS stimulated de novo synthesis of 
UCP2 protein, 2 hours after LPS exposure; it is more probable that they reflect early 
macrophage infiltration into the lung. UCP2 protein expression has been shown in 
macrophages and several studies suggest that UCP2 function may be more limited to 
specific cells types such as thymocytes47 and macrophages68. In the early stage of 
sepsis, macrophages are recruited to lung to help fight infection in this sensitive tissue. 
It is possible that a proportion of mitochondria isolated from septic lung tissue 
originated from these infiltrating macrophages and it is their UCP2 expression that is 
reflected in our results for this tissue. The results from samples isolated from rat pups 
culled 6  hours after LPS and saline injection suggest that this effect is diminished at 
later stages of sepsis. Further studies could be made to examine macrophage and 
neutrophil infiltration histologically or by marker enzyme measurement and to compare 
this with UCP2 expression.
The amount o f UQ9 was diminished in mitochondrial preparations from 
endotoxic lung tissue when compared to control from rat pups culled 6  hours after LPS 
and saline injection. The lack of impact o f sepsis on U Q 10 expression and the temporal 
separation of the effect of sepsis on UQ9 and UCP2 protein expression questions the 
reported functional relationship between UCP2 and ubiquinone. It could be argued that 
if such a relationship existed then an increase in UCP2 protein expression should be 
met by a concurrent increase in ubiquinone. Studies examining the relationship 
between UCP2 and ubiquinone in E.coli inclusion bodies have suggested that 1-2 
nmols o f UQ 10 (or a UQ 10 molar ratio o f 80:1 UCP2  dimer) were sufficient to activate 
UCP2 . Given the reported low level of UCP2 native protein expression , the levels of 
UQ 10 reported in our study should be more than enough to support UCP2 activity. Any 
change in the amount of UQ 10 needed to support UCP2 function during sepsis would be 
masked by pool o f UQ 10 already present in the mitochondria.
The length o f the hydrophobic isopAenoid side chain in ubiquinone has been 
shown to be important for the activation of UCP2. A minimum chain length of 10-13 C 
atoms has been described for UCP2 activation in UCP2 expressing inclusion bodies 
from E.coli31. This and the suggested low level o f Ubiquinone required for UCP2 
activation indicate that the decrease in UQ9 from septic samples compared to controls 
from rat pups culled 6  hours after LPS and saline injection found in our experiments
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were not a result o f its relationship with UCP2. Other studies have suggested that 
antioxidant damage increases the catabolism of UQ9 in a range of tissues71,72,73,74. It is 
possible that the oxidative stress of endotoxaemia causes an increased consumption of 
UQ9 and that this accounts for the decrease in lung mitochondria from rats culled 6  
hours after LPS injection.
Little is known about the subtle differences in the function o f UQ9 and UQioin 
different tissues. It is interesting to note that the UQ9 /UQ 10 ratio is markedly different 
between spleen and lung. This would suggest that there are some differences in 
function.
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5. Reactive Oxygen Species Production in Macrophages
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5. Reactive Oxygen Species Production in Macrophages
5.1 Background
Phagocytes play an important role in the host defence against microorganisms. 
In response to stimuli they assert microbicidal effects, producing proteolytic enzymes 
and reactive oxygen metabolites. This occurs via a co-ordinated sequence of 
biochemical events, known as the oxidative burst. The sequence is marked by a rapid 
uptake o f oxygen molecules that are then reduced to superoxide anion. The reaction is 
catalyzed by NAD(P)H oxidase, using NADPH or NADH as the electron donor 75. The 
oxygen free radical is subsequently converted to hydrogen peroxide by spontaneous or 
enzyme mediated dismutation (catalysed by superoxide dismutaSe).
The UCP2 knockout mouse has implicated UCP2 in the regulation of reactive
z o
oxygen species (ROS) in macrophages during the oxidative burst . Mice lacking UCP2 
were resistant to Toxiplasma gondi infection and their macrophages were found to 
contain higher levels o f ROS than wild type mice. Earlier studies have suggested that
nn
the activity o f UCP2 is functionally dependant on ubiquinone and may be stimulated 
by the by retinoids30’47. We have attempted to study the level o f ROS production in 
human macrophages in order to determine whether ubiquinone or retinoids affect ROS 
production.
Many methods exist for monitoring oxidative burst in macrophages. Some 
groups have measured the level of oxygen consumption utilising hexose 
monophosphate shunt activity or chemiluminescence76, whereas others looked at the
77formation o f redox products and protein iodination using tetrazolium dye reduction . 
Reactive oxygen species can be measured directly.
A simple rapid assay for measuring ROS generation from macrophage 
populations using membrane permeate 2’,7’-dichlorofluorescin diacetate (DCFH-DA) 
has been described 78. The non-fluorescent substrate, DCFH-DA, diffuses easily 
through the plasma membranes of macrophages and is trapped within the cells upon 
hydrolysis to non fluorescent 2 ’,7’ dichlorofluorescin (DCFH). Intracellular oxidation 
by ROS converts this compound into the green fluorochrome, 2 ’,7’ dichlorofluorescein
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(DCF) (Figure 5.1). Measuring the fluorescence from macrophage populations 
incubated with DCFH-DA can give an accurate indication of the level of ROS 
evolution. Unlike many other studies on oxidative burst in phagocytes 79, this method 
does not rely on flow cytometry, but measures the fluorescence from cells incubated 
with DCFH-DA directly.
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Figure 5.1 Diagram showing the conversion of 2’,7’-dichlorofluorescin diacetate to fluorescent 2 \T  
Dichlorofluoresein by intracellular ROS.
The results from this study were also compared to a microplate assay o f 
macrophage ROS production based on tetrazolium dye reduction.
5.2. Methods
5.2.1. Isolation o f  monocytes/macrophages from  peripheral whole blood.
2 0 ml of blood from healthy adult volunteers was collected in heparinized tubes 
and mixed 1:1 with phosphate buffered saline (PBS). 20 ml o f this mixture was then 
carefully layered onto 10 ml of Lymphoprep in 50 ml falcon tubes. The tubes were then 
placed a centrifuge set at 15°C, and was centrifuged for 30 mins, at 2000rpm, in a 
swing out rotor with the brake off. This process allowed the white mononuclear cell 
layer to be isolated in a distinct band at the sample/medium interface. The mononuclear 
cells from each o f the tubes were removed using 2 ml plastic pipettes and pooled into a 
single tube. These cells were then washed twice with 20ml o f PBS by spinning at 
1200rpm for 10 minutes. After this stage the cells were re-suspended in 10ml Hanks 
Balanced Salt Solution (HBSS) and counted using a haemocytometer (see section 5.2 
below). The cell count was then used to determine an appropriate level of dilution that 
would result in an approximate cell density o f 2.5 x l0 5/ml. Control aliquots were 
diluted in HBSS. Aliquots used to assess the effects o f particular compounds on 
reactive oxygen species production were diluted in HBSS with the appropriate 
concentration o f the compound.
5.2.2. Monocyte viability count
After each incubation period the viability o f the macrophages was assessed. 
50pl o f each sample was removed and placed into a 1ml eppendorf tube to which was 
added 50 pi o f 1% typhan blue solution and lOOpl o f HBSS. This mixture was vortexed 
briefly before being transferred to a haemocytometer and covered carefully with a glass 
cover slip. The samples were analysed under light microscopy and live cell count and 
percentage viability were recorded. Viable macrophages were identified by 
morphology as shiny, bright white cells. Dead cells appeared blue due to the uptake of 
trypan blue.
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5.2.3. Standard curve for 2,7-dichlorofluorescein.
Appropriate amounts of DCF were diluted in methanol to give a range of 
solutions from O.l-l.OnM DCF. The solutions were placed in fluorescence cuvettes and 
triplicate measures o f the fluorescence from each were taken at 504nm emission, 523
o n
excitation spectra , using a Perkin Elmer LS-3 fluorimeter. These results were then 
used to describe the standard curve for DCF. A standard curve is shown in figure 5.2.
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Figure 5.2. S tandard Curve DCF. Pmol DCF(Sigma), dissolved methanol. Fluorescence measured at 
504nm excitation and 523 emission spectra in Perkin-Elmer LS-3 fluorescence spectrometer at 37 °C. 
DCF concentration is proportional to absorbance at 504nm emission, 523nm excitation, between the 
limits of 0.1 and 0.7 pmol DCF.
5.2.4 Cuvette assay fo r  reactive oxygen species production.
450pl aliquots o f the macrophage preparation (approximate cell density, 
2.5x105/ml) were placed in 20 ml glass scintillation tubes to which was added 50pl of 
lOOpM DCFH-DA. These aliquots were then gassed with 95% O2 , 5% CO2 , fitted with
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rubber seals and incubated in the dark at 37°C in a shaking water bath for prescribed 
incubation periods.
The cuvette assay was used to assess reactive oxygen species production in 
control populations of macrophages and in those to which various compounds had been 
added. These compounds were introduced to the macrophages at the primary dilution 
stage to give final listed concentrations of; Zymosan (125pg/ml), Lipopolysaccharide 
(LPS; 90pg/ml), (4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-l- 
propenyl] benzoic acid) (TTNPB,a retinoid analogue. 4pM ) Phorbol myristate acetate 
(PMA; 250 ng/ml), Ubiquinone 10 (UQio; 11.5uM solution).
5.2.5 Non continuous measurement (methanol added).
After the defined incubation period, 2.5ml o f ice cold methanol was added to 
both control and test aliquots and they were vortexed for 2 minutes. The resulting 
solution from each tube were transferred to fluorescence cuvettes and kept on ice until 
their fluorescence could be determined as above.
O 1
5.2.6. Preparation o f  ubiquinone multi-lamellar liposomes
16 mg o f di-myristylphosphatidylcholine (DMPC, Sigma) was dissolved in 1ml 
of ethanol containing lm g o f ubiquinoneioat a Qio/DMPC ratio of 1:16. This solution 
was then evaporated under nitrogen, dispersed in degassed PBS buffer pH 7.4, and 
vortexed and sonicated at 40 °C for 20 minutes. The emulsion was then centrifuged at 
lOOxg for an hour. The resulting supernatant contained the multilamellar liposomes. 
The concentration o f ubiquinone present in the supernatant was examined by HPLC 
(for methods, see section 4.2.4.)
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5.2.7. Microplate Assay.
Isolated macrophages were suspended in PBS (pH7.4) at a concentration of 105 
cells/ml. 1 0 0  pi o f this suspension was added to each well of a microplate and the 
microplate was incubated for 2 hours at 37°C in a 5% O2 , 95% C 0 2 atmosphere. After 
the initial incubation period lOOpl of the effector reagent, diluted in PBS to give the 
final listed amounts of each regent, were added to each well.
LPS 90pg/ml 
TTNPB 4pM  
PMA 250ng/ml 
UQ 10 1 1.5pM
Immediately after the addition of the effector reagents, lOOpl o f PBS containing 
20mg/ml Nitro-blue-tetrazolium NBT and 5% glucose was added to each microplate 
well. The Microplate was then incubated for a further 3 hours, in a 5% C 02, 95% air 
Atmosphere, at 37°C.
At the end o f this incubation period, the supernatants from each well were 
discarded and the wells were washed 4 times with 70% methanol. Once the wells had 
dried lOOpl o f 2M potassium hydroxide was added to each, followed by lOOpl of 
dimethylsulphoxide. This produces the yellowed colour product. The absorbance o f this 
product was measured at 630nm using an automated plate reader.
To establish whether there were any intrinsic effects of each of the medium 
additives on formazan levels microplate wells prepared with appropriate concentration 
o f each medium and NBT were incubated without macrophages. The wells were 
incubated and washed with methanol under the same conditions as the with 
macrophage assay. Once the potassium hydroxide and dimethylsulphoxide were added 
absorbance measurements were taken at 630nm and the level o f formazan assessed.
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5.3. Results.
5.3.1. Macrophage ROS stimulation
Incubation of monocyte preparations with known macrophage stimulators of the 
oxidative burst, Zymosan and PM A at concentrations greater than 500ng/ml and
j
250ng/ml respectively, caused a significant increase in fluorescence. This demonstrated 
it was possible use cuvettes to study the level of ROS production from short term 
cultures o f human macrophages, treated with DCFH-DA. Using cuvettes meant that 
only one sample could be measured at one time point. To adjust for this in initial 
experiments, reactions in each incubation media were stopped at specific time intervals 
with methanol ( 1 0 0 %), before fluorescence readings were taken (section 5 .2 .5 )
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Figure 5.3. ROS production from stimulated and control macrophage suspensions: Macrophage 
preparations were incubated at 37°C in the dark. The Reaction was stopped at each time point by the 
addition of 2.5ml methanol (100%). Cell viability 95%, n=3. Values are given as Mean ±SEM (error bars 
to small to be visible)
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5.3.2. Increasing sample size.
The non-continuous method limited the sample size as stopping the reaction 
with methanol meant that a new sample was required with each time point. We studied 
the possibility of implementing a continuous measuring procedure. Samples were 
measured directly in the fluorimeter without the addition o f methanol to the 
macrophage cultures. An initial experiment demonstrated that it was possible to 
measure fluorescence directly from the samples. However, the study showed exposure 
to light from the fluorimeter caused increased levels o f fluorescence from the cultures 
(Figure 5.4.). It was not clear whether this was caused by degradation o f DCFH-DA to 
DCF by exposure to light alone, or whether macrophage ROS production was 
stimulated.
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Figure 5.4. ROS production from control and stimulated macrophages, prolonged incubation.
Methanol was not added to the culture media. A solid joined line indicates a 10-minute period of 
continuous measurement that for each sample was restored after 20 minutes A dotted line indicates the 
time period in which the sample was not exposed to light form the fluorimeter .
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Despite the intrinsic fluorescence caused by the measuring procedure, it is 
likely that the additional increase from control values in PMA and LPS are due to their 
effects on macrophage ROS production. To remove the confounding factor presented 
by prolonged exposure to the fluorimeter, subsequent experiments kept light exposure 
to a minimum, measuring only at specific time points.
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5.3.3 Continuous Measurement
In order to know whether any of the compounds directly caused fluorescence of 
DCFH-DA, they wore incubated they were incubated with media in the absence of cells 
and the fluorescence was recorded.
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Figure 5.5. Control Assay. Incubation of DCFH-DA with various compounds. Values shown as Mean 
±SEM, n=3.
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None of the compounds seemed to have a dramatic effect on DCFH-DA 
fluorescence that was different from control. However, there was a slow hydrolysis of 
DCFH DA solution over time, resulting in a slow increase in fluorescence. Despite 
this, it was still possible to conclude that changes reported with different DCFH-DA 
macrophage cultures are based on the compounds different effects on macrophage ROS 
production.
5.3.4. Exposure to LPS
By keeping the period of light exposure to a minimum ,a clearer picture o f the 
effect o f LPS on macrophage culture was established
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Figure 5.6. ROS production from stimulated and control macrophages, LPS exposure. Samples 
were incubated in the dark at 37°C and the periods of exposure to light in the fluorimeter were kept to a 
minimum. Values shown as Mean ±SEM n=3, Cell Viability 95%
Incubation with LPS caused a smaller increase in ROS than PMA. However, 
both compounds increased ROS above the control level. The increase in ROS induced 
by LPS was important as it demonstrates that the oxidative burst response to this 
initiator o f sepsis in vivo could be reproduced in vitro with macrophages.
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5.3.5 TTNPB
UCP2 has a proposed role in regulating ROS production in macrophages by 
modulating proton leakage and superoxide production at the inner mitochondrial 
membrane44. Studies have demonstrated that retinoid derivatives can enhance 
uncoupling by UCP1 and 2 in recombinant yeast models30 and stimulate ROS 
production in thymocytes through UCP2 activation47. Both studies cite TTNPB as a 
strong and specific enhancer o f UCP2 activity.
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Figure 5.7. Effect of TTNPB on LPS induced ROS production. Values represented as Mean ±SEM, 
n=3, Cell viability 95%.
An investigation into the effect of TTNPB incubation with both LPS stimulated 
and control macrophages showed TTNPB had little effect on ROS production.
98
5.3.6 Ubiquinone
Ubiquinone is another compound reported to have an effect on UCP2 18 Echtay 
et al present ubiquinone as an obligatory co-factor for UCP2’s uncoupling function. In 
a reduced form ubiquinone is a natural quencher o f ROS. Ubiquinone’s effect on ROS 
production from macrophages may therefore be two fold. Firstly it may affect UCP2 
function and secondly it may directly influence ROS scavenging. However, UQ was 
added in the oxidised form rather then the reduced form which is directly antioxidant. 
Ubiquinone is highly hydrophobic and insoluble in aqueous solutions. To ensure 
macrophages could take up UQ they were incubated with multi-lamellar liposomes of 
UQ10 prepared in PBS (methods section, 5.2.6.).
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Figure 5.8. Attenuation of ROS macrophage ROS production with UQ10 Values represented as Mean 
±SEM, n=3, Cell Viability 95%.
When incubated with UQ the level of ROS production appeared to be reduced 
in both control and LPS stimulated macrophages. It is difficult to determine whether 
this effect is the result o f UQ stimulating UCP2 activity or of intrinsic ROS quenching.
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5.3.7. Microplate Assay
The results from the DCFH-DA investigation into ROS production were 
interesting. However, this method was not the most efficient way of accumulating 
significant data. A micro-plate assay would offer a simple yet effective solution. In the 
absence o f a fluorometric micro-plate reader, a ROS assay using nitro-blue-tetrazolium 
(NBT) was formulated.
In the presence o f redox products, NBT is reduced, precipating formazan that 
reacts with KOH and DMSO to form a soluble blue compound that absorbs at 630nm. 
A high turn over o f ROS leads to accumulation o f a high concentration of redox 
products giving a stronger reaction to NBT.
The data obtained from these experiments were subject to statistical analysis by 
one way ANOVA parametric analysis, using Tukey's multiple comparison test.
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5.3.8. Control Assay
To account for any intrinsic effect that any studied compound might have on 
tetrazolium dye reduction, the microplate assay was set up with the appropriate 
concentration o f each compound and tested in the absence o f macrophages.
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Figure 5.9. Absorbance from media in the absence of cells. Appropriate concentrations of each 
compound were added to microplate wells and their absorbance was measured in the absence of 
macrophages. Values represented as mean ±SEM, n=12.
The level o f formazan was about a sixth o f that found in the presence of 
macrophages and there were no significant differences between compounds. Changes 
in absorbance when compounds were incubated with macrophages are likely to be 
related to their interaction and their effect on the oxidative burst
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5.3.9. Measuring ROS production
Macrophages were incubated in micro wells containing different combinations 
o f LPS, PMA, TTNPB and UQ. After three hours formazan was solublised using 
DMSO and KOH and read on a Dynex microplate reader at 630nm. {Methods Section 
8: Microplate assay)
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Figure 5.10. ROS production in microplate culture. Macrophages incubated at 37°C for 3 hours with 
described media. Absorbance read against reagent blank, at 630nm in Dynex plate reader. Values 
represented as Mean ±SEM, n=18.
As much data was accumulated from each micro-plate experiment the data was 
separated into groups and values were presented as the difference from control value.
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5.3.10. Incubation with active compounds.
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Figure.5.11. Incubation with enhanced media, difference from control. Values represented as 
absorbance units against control value, Mean ±SEM,11=18. p values shown are calculated Vs control.
Both LPS and PM A incubation caused a significant increase in absorbance at 
630nm as compared to control. This indicates that a higher concentration of formazan 
was present in these wells. It is likely that this was produced as a direct result o f an 
increase in the level of ROS produced by the PMA and LPS stimulated macrophages. 
These results compared favourably with that from the DCFH-DA studies suggesting 
both are viable measures of the oxidative burst response in vitro.
The detected decrease in absorbance readings from cultures incubated with 
TTNPB, as compared to control were not significant in this study.
Incubation with UQ seemed to increase absorbance readings although this was 
not significant. There is evidence that suggests UQ in mitochondria may be involved in 
ROS generation and this might explain the slight increase in absorbance readings. 
Conversely, in its reduced form, UQ acts as an antioxidant both in vitro and in vivo and
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as a reported quencher of ROS and could be expected to reduce formazan levels in this 
experiment. The increase in absorbance reading was not significant. When UQ was 
incubated with macrophage free NBT solution it had no significant effect on 
absorbance levels. This suggests that UQ alone does not potentiate the level of 
formazan.
Incubating macrophages with a combination of UQ and TTNPB seemingly 
caused the greatest reduction in absorbance but this was not significant. Incubation with 
TTNPB alone had indicated that it was acting to stimulate UCP2 uncoupling activity in 
macrophages. UQ has a reported role as a co-factor for UCP2s’ uncoupling function. 
Although not statistically significant, these results could provide cursory evidence to 
support the hypothesis that UCP2 has an uncoupling function in macrophages and that 
it is supported by UQ.
5.3.11. Attenuating ROS production under stimulated conditions.
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When co-incubated with known stimulators of ROS, both TTNPB and UQ seemed to 
attenuate ROS production. A significant reduction was only found with the LPS 
stimulated samples (LPS vs. LPS+UQ+TTNPB P<0.001). This may reflect differing 
mechanisms o f macrophage stimulation between LPS and PMA.
In both cases UQ caused a reduction in absorbance. This is interesting given that 
incubation with UQ alone had little effect on the absorbance reading o f the micro-plate 
cultures. Although the results are not statistically significant it is possible to 
hypothesise that UQ’s antioxidant function is only active under the reducing conditions 
imposed by PMA or LPS co-incubation and does not have an effect under native 
conditions. Superoxide has been reported to activate UCP2 activity48. It is possible that 
PMA and LPS stimulated ROS production activate UCP2 mediated uncoupling in the 
mitochondria of these macrophages and that this uncoupling activity is supported by 
the supplementary UQio . In this way UQio supplementation would only have an effect 
on ROS production in stimulated macrophage cultures.
It is difficult to make a judgement as to the mechanism by which TTNPB or UQ cause 
the possible reduction in ROS from stimulated Macrophages. However, the significant 
reduction in absorbance seen when both UQ and TTNPB are incubated together with 
LPS stimulated macrophages, suggests that their actions are synergistic. Although this 
is not seen with PMA stimulated macrophages these results do support the hypothesis 
that UQ can function with UCP2 to reduce oxidative stress in macrophages. In this way 
TTNPB would function to stimulate UCP2 uncoupling activity and UQ 
supplementation would ensure that a sufficient pool o f UQ was available to support 
UCP2s’ uncoupling function as an essential co-factor. Increased UCP2 uncoupling 
would cause a decrease in the mitochondrial membrane potential and a consequent 
decrease in the production of ROS.
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6. Discussion
6. Discussion
Using endotoxaemia in suckling rat pups as a model for neonatal sepsis we have 
established that the hypothermia observed in this model is accompanied 
hypometabolism, as reflected by decreased energy expenditure and oxygen 
consumption. Previous studies of neonatal sepsis have associated the observed 
decrease in body temperature with impaired hepatocyte mitochondrial metabolism and 
suggested that this could be due to inhibition o f the proton leak7. If the function of 
UCP2 was to drive heat production by acting as a proton leak then it is possible that 
changes in body temperature in response to sepsis would be reflected by the level o f its 
expression. The finding o f increase UCP2 expression with a decrease in body 
temperature is at odds with this.
UCP2 mRNA is reported to be ubiquitously expressed in the mammalian body. 
Its expression in the liver and up-regulation in hepatocytes during sepsis suggested that 
UCP2 could be involved in the fever response to sepsis43,62. We investigated the 
expression o f UCP2 protein in rat pups by western blotting. The strongest positive 
reactivity to the UCP2 antibody was from mitochondrial samples isolated from spleen 
and lung tissue. Western blots of mitochondrial samples from liver tissue gave rise to 
indistinct bands in relation to UCP2 control, suggesting that a low level of UCP2 
protein existed in this tissue. A comparative analysis of UCP2 western blotting from 
control and UCP2 knock out mice reported that UCP2 expression was robust in spleen, 
lung, stomach and white adipose tissue. Detection in other preparations such as liver, 
BAT and brain mitochondria were reported to be non specific as the 32 kDa band 
detected by UCP2 western blotting of these samples were also present in samples from 
UCP2 ''' mice44. It is likely that the low level o f reactivity o f liver mitochondria to the 
UCP2 antibody in our study of neonatal rats is due to lack o f antibody specificity rather 
than evidence o f UCP2 protein. Another explanation could be that the reactivity to the 
antibody was due to the presence of kuppfer cells in our liver samples. The pattern o f 
UCP2 protein expression from our study does not support a role for this protein in 
whole body thermogenesis. This is in agreement with other UCP2 western blotting 
investigations performed in adult mice, whilst these studies were in progress.
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To investigate the relationship between UCP2 protein expression and sepsis, we 
focused on the expression of UCP2 in lung and spleen mitochondria in control and 
endotoxic rat pups. UCP2 protein expression normalised for total mitochondrial protein 
content by citrate synthase was increased in lung mitochondria from rats culled 2  hours 
after LPS injection. This effect did not seem to be maintained in mitochondrial samples 
from rats culled 6  hours after LPS injection. The level o f UCP2 expression in spleen 
was unchanged between control and septic samples from rats culled at both 2  and 6  
hours after LPS and saline injection.
It would be interesting to study the level o f UCP2 expression in rat pups after 
extended periods o f endotoxaemia. A similar study o f UCP2 expression in adult mice 
found that significant induction of UCP2 expression did not occur until 10 hours after
/o
exposure to LPS . Future work might determine the temporal expression pattern of 
UCP2 over a 24 hour period. However it is likely that suckling rat pups will stop 
feeding during later stages of endotoxaemia and this may affect the results of such a 
study.
Inhibition o f the proton leak across the inner mitochondrial membrane could be 
a factor contributing to the hypometabolism observed in this model o f sepsis. If the 
expression o f UCP2 was related to this observed hypometabolism we might expect to 
observe a decrease in band density in UCP2 western blots from mitochondria isolated 
from septic tissues when compared to controls. In our study, the only significant 
difference in UCP2 protein expression between mitochondria isolated from control and 
septic rat pups was a short lived increase in endotoxic lung mitochondria. Results from 
UCP2 western blotting do not suggest UCP2 expression is related to a hypometabolism 
during neonatal sepsis. Moreover, the magnitude o f temperature decline and drop in 
oxygen consumption recorded by indirect calorimetry o f septic rat pups appears too 
large to be accounted for by the proton leak alone.
An increase in UCP2 protein expression in lung mitochondria during sepsis has 
been observed by other authors in adult mice68. In that study, UCP2 induction was not 
apparent until 10 hours after exposure to LPS. The kinetics o f this induction seemed 
consistent with a primary immune response leading to oxidative burst in the lung. Our 
investigation focused on the earlier stages of infection and found UCP2 protein
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expression was increased in lung mitochondria from rat pups culled just 2  hours after 
LPS exposure. The lung has a unique relationship with its environment. It is constantly 
exposed to microbial challenges to which it must respond to quickly in order to 
preserve gaseous exchange. One of the early innate immune responses is a recruitment 
of macrophages to the lung. UCP2 expression has been found in macrophages and it 
has been suggested that they may regulate their UCP2 expression in response to 
infection47. It is unlikely that the increase in UCP2 protein expression found in lung 
mitochondria represents an increase in UCP2 synthesis but it could reflect macrophage 
infiltration into this organ as part of the immune response.
The difference in UCP2 protein expression between control and septic lung 
mitochondria is not maintained to a significant level in rats culled 6  hours after LPS 
injection. If the level o f UCP2 protein in mitochondrial preparations from the lung did 
drop between 2 and 6  hours after exposure to LPS it is possible that this could be due to 
macrophage redistribution away from the lung. Isolated macrophages have been shown
/o
to decrease their UCP2 mRNA expression when exposed to LPS and the apparent 
drop in UCP2 expression in lung mitochondrial preparations could also be as a result o f 
the macrophages present in this sample decreasing UCP2 expression to increase 
bacterial killing. To study this further it would be necessary to correlate UCP2 
expression with lung content of macrophages.
The uncoupling activity o f UCP2 is reported to be functionally dependent on 
the presence of ubiquinone . To investigate this relationship further, we examined the 
level o f ubiquionones 9 and 1 0  (UQ9 and UQio) in our mitochondrial preparations. Our 
results suggest that the level of UQ9 is decreased in lung mitochondria from septic rats 
culled 6  hours after LPS injection. Oxidative stress has been reported to cause an 
increase in UQ9 and UQio levels in the plasma membrane and it is possible that this 
additional ubiquinone is recruited from the mitochondria82. The decrease of UQ9  
observed in septic lung mitochondria could reflect a redistribution of UQ9 to the plasma 
membrane as a form of oxidative defence. It has been suggested that conditions o f
• • 83oxidative stress can impair ubiquinone biosynthesis or increase its catabolism . The 
decrease in UQ9 in septic lung mitochondria may simply reflect an increase in its 
decomposition. Whether it is by increased catabolism or dispersal from the 
mitochondria it is unlikely that this decrease is related to UCP2 protein expression. It is
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reported that the minimum length o f the side chain in ubiquinone needed to activate 
UCP2 is 10 isoprenoid units37. If a relationship did exist between UCP2 protein 
expression and ubiquinone it is likely that it would be with UQio. The levels of UQio in 
this study were unchanged between control and septic samples collected from rats 
culled at 2 and 6  hours after LPS and saline injection. An investigation into the 
relationship between UCP2 and UQio in E.coli inclusion bodies has suggested that a 
UQio molar ratio of 80:1 UCP2 dimer is sufficient to activate uncoupling37. Given the 
low level of Protein expression described for UCP2, the level o f UQio reported in our 
study is probably more than sufficient to activate uncoupling. It is likely that any 
change in the level of UQio that might be needed to support UCP2 activity would be 
masked by the pool o f UQio already present in these mitochondria. It has not been 
possible to draw any conclusions about the relationship between UCP2 and ubiquinone 
by comparing the relative levels of these compounds by western blotting and HPLC 
analysis. It may be possible to use a linker molecule to determine whether UCP2 and 
ubiquinone are physically associated in the mitochondrial membrane.
The distribution of UCP2 protein and the changes in its expression revealed by 
western blotting in our model of neonatal sepsis suggested that UCP2 may have a role 
in the immune response and may be expressed in macrophages. It was not possible to 
determine UCP2 protein expression in isolated macrophages using our methodology for 
western blotting. The blood volume in rat pups was too low to give workable yields of 
isolated macrophages and western blots o f human macrophages had very high 
background reactivity (results not shown), this was probably due to lack of antibody 
specificity. Macrophage UCP2 expression has been demonstrated and evidence from 
the knock out model of UCP2 strongly suggests that UCP2 is involved in regulating 
macrophage ROS production44’68. The results from our ROS assays in macrophage 
populations support the hypothesis that UCP2 activity may mediate the generation of 
ROS.
We demonstrated that it was possible to measure ROS production from 
populations o f isolated human macrophages using both DCFH-DA and tetrazolium dye 
reduction. Macrophage populations co-incubated with DCFH-DA and LPS had 
increased fluorescence compared to controls, indicating a higher level of ROS. 
Similarly treated cultures of macrophages had lower fluorescence when either TTNPB
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or UQ was added to the culture media, suggesting that these compounds were 
attenuating macrophage ROS production. These findings were supported by results 
from our microplate assay of macrophage ROS production using tetrazolium dye 
reduction. Here we demonstrated that the PMA and LPS stimulation o f ROS production 
from human macrophages was significant. TTNPB and UQ were both shown to 
attenuate this response. However, the only statistically significant reduction in 
stimulated ROS production was found when macrophage populations exposed to LPS 
were incubated with UQ and TTNPB simultaneously. Ubiquinone is a known quencher 
of ROS and it is reported that retinoic acids can reduce the oxidative burst in 
macrophages5. It is possible that both these compounds reduce the ROS production o f 
stimulated macrophages by mechanisms independent o f UCP2. However the 
significant decrease in ROS from LPS stimulated macrophages observed when UQ and 
TTNPB are present together in the culture media suggests that their actions are 
synergistic. TTNPB has been reported to specifically activate UCP230 and the activity 
of UCP2 is reportedly dependant on the presence of UQ38. Given that previous studies 
have implicated UCP2 in the regulation of macrophage ROS, it seems possible that the 
focus o f TTNPB and UQs’ synergy in our experiments could be a relationship with 
UCP2 activity.
A recent paper by Echtay et al50 supports the hypothesis that UCP2 function 
may be related to mediating the level of ROS. They report that superoxide activates 
mitochondrial proton transport through UCP2 and suggests that activation of UCP2 is 
from the matrix side of the inner mitochondrial membrane. In this way it is easy to see 
how UCP2 could function by uncoupling in response to an increase in internal 
oxidative pressure. The majority o f ROS produced during sepsis is be generated outside 
the mitochondria. Echtay et al have demonstrated that exogenous superoxide anions 
can reach the mitochondrial matrix and it will be interesting to see if  the results from 
these experiments can be reproduced in other cell types, particularly in macrophages 
and other immune specific cells.
A conclusive discussion of UCP2’s function and its relationship to the 
biochemical and physiological response to infection in neonates is beyond the scope of 
this study. However, the findings we report suggest that UCP2 does not have a role in 
maintaining body temperature during sepsis, but support other studies that suggest it
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UCP2 is involved in protecting the body against the detrimental effects of 
oxygen species.
reactive
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